Books By Dr. Reiss

  • The Good News About Estrogen
    The Good News About Estrogen
  • Natural Hormone Balance
    Natural Hormone Balance
  • How to Make a Pregnant Woman Happy
    How to Make a Pregnant Woman Happy
  • The Natural Super Woman
    The Natural Super Woman
  • How to Make a New Mother Happy
    How to Make a New Mother Happy

The Natural Superwoman

Uzzi Reiss, M.D

Dr. Reiss dispels the myths about hormone replacement therapy with scientific evidence explaining the incredible benefits of bioidentical hormones. He illustrates how nutrition, mental and physical activity, and ideal mood balance can work hand-in-hand with hormones to prepare women for the challenges she faces every day and enhance her overall health. The Natural Superwoman explains:

  • What specific hormones can enhance energy, sexuality, and memory; heal dry skin treat sleep disorders; alleviate anxiety and depression and eliminate night sweats;
  • Why women should take magnesium instead of calcium to guard against osteoporosis;
  • How simple diet tweaks that help with weight loss can also promote sound sleep, bone health, cardiovascular benefits, and more;
  • Why women may wish to reconsider their current form of birth control

Dr. Reiss takes the confusion out of the medical information you need to know. In clear, non-technical language, he thoroughly explains:

  • the important difference between standard chemical hormone prescriptions and natural hormone replacements
  • which hormone replacements are best for you and how to adjust them to your maximum individual benefit
  • how to take hormones without worry
  • how to choose the most effective hormonal gel, cream, pill, or sublingual drops, and when to use them

This book offers accessible yet authoritative information from a physician with more than thirty years of experience understanding and working with the personal needs of women. The Natural Superwoman shows readers how to take control of their well-being, live vibrantly, and become the best possible versions of themselves-naturally.

In spite of the fact that my practice is really elective, that we don’t advertise through insurance referral or any other means, there are still a large percentage of woman that elect to come see me, who on certain levels are still confused about the issue of how healthy and how safe it is to use bioidentical hormones. This book was written for two reasons. First, to supply these woman nutritional alternatives to their problems such as diet, stress release, physical activity, vitamins, minerals, herbs and nutritional supplementation. Second, a) to give to these women the most updated information on why bioidentical hormones are safe, healthy, and important for our well being at any age; b) why avoiding taking bioidentical hormones, if needed, has a devastating effect on your health c) why it is even more dangerous to use chemicalized hormones to resolve your hormonal imbalance problem.

References from Natural Superwoman

Select a chapter to view its references.

P. 21:  Consistent proof that eating less is scientifically proven to increase lifespan extension: 

JAMA. 2004 Mar 10;291(10): 1226-30. Michels KB et al.

P. 21: Medical studies consistently proving that eating less increases lifespan: 

Microsc Res Tech. 2002 Nov 15;59(4): 335-8. Lane MA et al.

P. 21: Caloric reduction improves insulin sensitivity and decreases midsection fat: 

Toxicol Sci. 1999 Dec;52(2 Suppl): 49-55. Cefalu WT et al.; J Gerontol A Biol Sci Med Sci. 2004 Oct;59(10): 1007-14. Cefalu WT et al.

P. 21: Caloric reduction reduces LDL cholesterol, triglycerides and weight: 

Free Radic Biol Med. 2007 Mar 1;42(5): 665-74. Johnson JB et al.

P. 22: Calorie reduction lowers rate of mitochondrial free-radical cell formation:

Int J Biochem Cell Biol. 2002 Nov;34(11):1340-54. Merry BJ et al.

P. 22: Calorie reduction lowers marker of oxidative stress: 

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52): 19908-12. Hyun DH et al.

P. 22: Calorie reduction decreases TNF alpha and increases natural antioxidants: 

Free Radic Biol Med. 2007 Mar 1;42(5): 665-74. Johnson JB et al.

P. 22: Calorie reduction benefits breast cancer: 

JAMA. 2004 Mar 10;291(10): 1226-30. Michels KB.; Exp Biol Med (Maywood). 2007 Jan;232(1): 70-80. Cleary MP et al.; Interdiscip Top Gerontol. 2007;35: 176-92. Klebanov S.

P. 22: Calorie reduction protects genome by increasing repair and decreasing mutation: 

J Nutr Health Aging. 1999;3(2): 102-10. Raffoul JJ et al.

P. 22: Calorie reduction produces new neurons, increases apoptosis and helps DNA repair itself: 

Ann N Y Acad Sci. 2004 Jun;1019: 96-105. Hiona A et al.

P. 22: Calorie reduction decreases brain inflammation: 

Interdiscip Top Gerontol. 2007;35: 83-97. Morgan TE et al.

P. 22: Calorie reduction decreases oxidative stress in brain: 

Proc Natll Acad Sci U S A. 2006 Dec 26;103(52): 19908-12. Hyun DH et al.

P. 22: Calorie reduction decreases brain toxicity and increases memory consolidation: 

Brain Res Mol Brain Res. 2000 May 31;78(1-2): 154-62. Eckles-Smith K et al.; Neuroreport. 2005 Jul 13;16(10): 1129-33. Hashimoto T et al.

P. 22: 50% calorie reduction in obese women improves word recall: 

Int J Obes Relat Metab Disord. 1997 Jan;21(1): 14-21. Kretsch MJ et al.

P. 23: Caloric reduction programs show promise in reducing incidence of Alzheimer's: 

Interdiscip Top Gerontol. 2007;35: 159-75. Pasinetti GM et al.

P. 23: Bone loss with caloric reduction is mitigated if accompanied by physical activity: 

Arch Intern Med. 2006 Dec 11-25;166(22): 2502-10. Villareal DT et al.

P. 23: Caloric reduction prevents muscle fiber loss: 

FASEB J. 2004 Mar;18(3): 580-1. McKiernan SH et al.

P. 23: Caloric reduction preserves aerobic function in aging muscle: 

FASEB J. 2005 Aug;19(10): 1320-2. Hepple RT et al.

P. 23: Caloric reduction improves skin disease: 

J Physiol Anthropol Appl Human Sci. 2003 Sep;22(5): 237-40. Nakamura H et al.; J Physiol Antropol Appl Human Sci. 2000 Sep;19(5): 225-8. Kouda K et al.

P. 24: Caloric reduction into obese pregnant women has no negative effects for the fetus: 

J Nutr. 1984 Dec;114(12): 2247-55. Reynolds LK et al.

P. 24: Calorie reduction programs maintain reproductive hormones and menstrual cycles

Exp Gerontol. 2003 Jan-Feb;38(1-2): 35-46. Mattison JA et al.

P. 24: In healthy, lean females, inappropriate calorie reduction reduces T3 levels: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 3232-5. Fontana L et al.

P. 24-25: HGH increases during fasting: 

Growth Horm IGF Res. 2002 Aug;12(4): 198-207. Norrelund H et al.

P. 25: Dieting increases HGH levels in obese girls: 

J Clin Endocrinol Metab. 2002 Apr;87(4): 1885-93. Kasa-Vubu JZ et al.

P. 25: Age-related Melatonin decline arrested by 30% calorie reduction: 

J Clin Endocrinol Metab. 2001 Jul;86(7): 3292-5. Roth GS et al. ; Exp Gerontol. 2003 Jan-Feb;38(1-2): 35-46. Mattison JA et al.

P. 25: Long-term calorie reduction slows age-associated DHEA reductions: 

J Clin Endocrinol Metab. 2001 Jul;86(7): 3292-5. Roth GS. et al.

P. 25: Calorie reduction increases adiponectin while decreasing fat: 

Obes Surg. 2006 Nov;16(11): 1425-32. Kotidis EV et al.

P. 26: Caloric reduction mitigates kidney lesions: 

Gerontology. 2005 Mar-Apr;51(2): 83-93. Loupal G et al.

P. 26: Calorie reduction decreases liver faty size 40%: 

Obes Surg. 2006 Jun;16(6): 697-701. Lewis MC et al.

P. 26: Calorie reduction improves retina health: 

Bio Chem Biophys Res Commun. 2003 Sep 19;309(2): 457-63. Li D et al.

P. 26: Calorie reduction slows cataracts development: 

Exp Eye Res. 2004 Jan;78(1): 151-8. Wang K et al.

P. 26: Calorie reduction delays onset of glaucoma: 

J Glaucoma. 1997 Feb;6(1): 18-22. Li Y et al.

P. 26: 30-year studies on non-human primates indicate universal affect across species with calorie reduction: 

Microsc Res Tech. 2002 Nov 15;59(4): 335-8. Lane MA et al

P. 26: Reducing calories every other day offers benefits:

 Med Hypotheses. 2006;67(2): 209-11. Johnson JB et al.

P. 33: Ghrelin causes you to feel hungry and increase overall food intake: 

Diabetes. 2006 Nov;55(11): 3038-46. Chelikani PK et al.

P. 33: Ghrelin moves food out of stomach quickly: 

J Clin Endocrinol Metab. 2006 Sep;91(9): 3296-302. Levin F et al.

P. 33: Eating protein suppresses ghrelin: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 2913-9. Bowen J.

P. 34: Protein increases GLP-1, decreasing appetite: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 2913-9. Bowen J et al.

P. 40: R-Lipoic Acid reduces body weight and improves insulin sensitivity: 

Hormones (Athens). 2006 Oct-Dec;5(4): 251-8. Kamenova P.

P. 40: R-Lipoic Acid can be effective in controlling neurological damage: 

Invest Ophthalmol Vis Sci. 2006 Sep;47(9): 4077-82. Roberts R et al.; Diabetes Care. 2006 Nov;29(11): 2365-70. Ziegler D et al.

P. 40: R-Lipoic Acid can decrease glycation: 

Pharmazie. 2005 Oct;60(10): 772-5. Thirunavukkarasu V et al.

P. 40: Chromium is efficient in treating insulin resistance: 

Diabetes Care. 2006 Dec;29(12): 2764-5. Martin J et al.; Folia Med. (Plovdiv). 2005;47(3-4): 59-62. Vladeva SV et al.; Mutat Res. 2006 Nov 7;610(1-2): 93-100. Pattar GR et al.

P. 40: Cinnamon extract has anti-diabetic potency and improves insulin sensitivity: 

Eur J Clin Invest. 2006 May;36(5): 340-4. Mang B et al.; Phytomedicine. 2007 Jan;14(1): 15-22. Subash Babu P et al.

P. 40: Vanadium may improve diabetic condition: 

Arch Biochem Biophys. 2005 Aug 15;440(2): 158-64. Mehdi MZ et al.; J Vet Sci. 2006 Dec;7(4): 391-5. Kim JM et al.; Clin Calcium. 2005 Jan;15(1): 49-57. Sakurai H.

P. 46: Moderately strenuous or small amount of activity will delay death: 

Scand J Public Health. 2006;34(5):480-7. Carlsson S et al.

P. 46: Cardiovascular exercise and weight training prevent arterial sclerosis: 

Sports Med. 2003;33(14):1013-35. Maiorana A et al.

P. 46: Exercise decreases frequency of breast, colon, prostate and lung cancers: 

Asian Pac J Cancer Prev. 2006 Jan-Mar;7(1):11-21. Kruk J et al.; Cancer epidemiol Biomarkers Prev. 2007 Feb;16(2):236-43. Sprague BL et al.

P. 47: Exercise improves antioxidant function: 

Life Sci. 2006 May 22;78(26):3074-81. Brites F et al.

P. 47: Activity is helpful for depression and overall well being: 

Pediatrics. 2006 Nov;118(5):2126-34. Daley AJ et al.; J Psychiatr Pract. 2006 Jul;12(4):205-13. Trivedi MH et al.

P. 47: Acute exercise reduces panic disorder: 

J Affect Disord. 2007 Aug 27; Esquivel G. et al.

P. 47: Cardiovascular conditioning improves memory: 

Am J Geriatr Psychiatry. 2006 June;14(6):538-45. Small GW et al.

P. 47: Strength training improves memory: 

J Aging Phys Act. 2006 Jan;14(1):59-73. Lachman ME et al.

P. 48: Very challenging exercise can lead to oxidative stress and DNA damage: 

Redox Rep. 2005;10(6):325-31. Briviba K et al.

P. 49: The older we are, we get more prone to oxidative damage: 

Ann N Y Acad Sci. 2001 Apr;928:236-47. Ji LL.

P. 51: Muscular fatigue may indicate oxidative stress and over training: 

Sports Med. 2006;36(4):327-58. Finaud J et al.

P. 51: Exercise decrease IVF outcomoe: 

Obstet Gynecol. 2006 Oct;108(4):938-45. Morris SN et al.

P. 52: L-Argenin before exercise is beneficial: 

Int J Sports Med. 2002 Aug;23(6):403-7. Schaefer A et al.

P. 52: D-Ribose can improve physical and cardio performance: 

Lancet. 1992 Aug 29;340(8818):507-10. Pliml W et al.

P. 52: L-Carnitine improves exercise tolerance: 

Am J Kidney Dis. 2003 Apr;41(4 Suppl 4):S35-43. Pauly DF et al.

P. 52: L-Carnitne benefits training, competition and recovery: 

Nutrition. 2004 Jul-Aug;20(7-8):709-15. Karlic H et al.

P. 53: L-Glutamine promotes muscle glycogen storage: 

J Appl Physiol. 1999 Jun;86(6):1770-7. Bowtell JL et al.

P. 53: L-Glutamine is important fuel for immune system cells: 

Nutrition. 2002 May;18(5):371-5. Castell LM.

P. 53: Supplementing L-Glutamine decreases incidence of illness in endurance athletes: 

Nutrition. 2002 May;18(5):371-5. Castell LM.

P. 53: L-Glutamine improves sugar balance before and after exercise: 

J Appl Physiol. 2005 Nov;99(5):1858-65. Iwashita S et al.

P. 56: Eating disorders and sexuality: 

Int J Eat Disord. 1996 Mar;19(2): 109-18. Wiederman MW et al.

P. 58: Men are more attracted to women when estrogen levels rise: 

Proc Biol Sci. 2006 Jan 22;273(1583): 135-40. Smith MJ et al.

P. 68: Negative impact of Women’s Health Initiative: 

Ob Gyn News October 1, 2006. Dixon BK.

P. 70: Premarin increases inflammation: 

Maturitas. 2003 Dec 10;46(4):245-53. Yilmazer M et al.; Atherosclerosis. 2006 Dec;189(2):436-42. Sumino H et al.; Menopause. 2005 Sep-Oct;12(5):552-8. Vitale C et al.; Atherosclerosis. 2006 Apr;185(2):347-52. Hu P et al.

P. 70: Bioidentical estradiol in cream form decreases inflammation: 

Gynecol Obstet Mex. 2006 Mar;74(3):133-8. Saucedo Garcia R et al.; Cytokine. 2005 Aug;31(4):251-7 Liu H et al.; J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. WangY et al.; Rheumatol Int. 2003 Nov;23(6):282-8. Lee YJ et al.

P. 70: Bioidentical estradiol does not increase CRP: 

Maturitas. 2005 Oct 16;52(2):111-8. Eilertsen AL et al.; Menopause. 2006 Sep-Oct;13(5):840-5. Rachon D et al.; Maturitas. 2003 Dec 10;46(4):245-53. Yilmazer M et al.

P. 70: Premarin and bioidential estradio in capsule/pill form increase CRP: 

Maturitas. 2005 Oct 16;52(2):111-8. Eilertsen AL et al.

P. 71: Premarin increases body fat and decreases lean body mass: 

Adv Ther. 2006 Mar-Apr;23(2):263-73. Delibasi T et al.

P. 71: Bioidentical estradiol decreases body fat: 

Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1251-63. Asarian L et al.; Psychol Med. 2006 Oct 12;:1-11. Edler C et al.; Fertil Steril. 2006 Dec;86(6)1669. Micheline CC et al

P. 71: Bioidentical estradiol promotes muscle growth and regeneration: 

J Appl Physiol. 2006 Jun;100(6):2012-23. McClung JM et al.

P. 71: Premarin increases cardiovascular events: 

Arch Intern Med. 2006 Feb 27;166(4):399-404. Lemaitre RN et al.; Atherosclerosis. 2006 Apr;185(2):347-52. Hu P et al.

P. 71: Premarin increases atherosclerotic vascular disease: 

Hum Reprod. 2006 Oct;21(10):2715-20. Ho JY et al.

P. 71: Premarin increases venous thrombosis: 

Arch Intern Med. 2006 Apr;166((7):772-80 Curb JD et al.

P. 71: Bioidentical estradiol cream does not increase blood clots or venous thrombosis: 

Circulation. 2007 Feb 20;115(7):840-5. Canonico M et al.

P. 71: Bioidentical estradiol protects the heart: 

Menopause. 2006 Jul-Aug;13(4):643-50. Zegura B et al.; Basic Res Cardiol. 2006 Jul 4; Beer S et al.; Menopause. 2001 Jul-Aug:8(4):252-8. Ventura P et al.; Ob Gyn News April 15 2005. Wildman RP. Page 28.; Fertil Steril. 2004:82:391-7. Mack WJ et al.; Ann NY Acad Sci. 1990;592:193-203. Stampfer M et al.; Hypertens Res. 2005 Jul;28(7):579-84. Sumino H et al.

P. 71: Premarin Increases systemic lupus erythematosus flares: 

Ann Intern Med. 2005 Jun 21;142(12 Pt 1):953-62. Buyon JP et al

P. 71: Premarin increases migraines: 

Maturitas. 2001 Apr 20;38(2):157-63. Nappi RE et al.

P. 71: Bioidentical estradiol is effective treatment for migraine: 

New Advance In Headache Research 4th add London-Smith Gordon 1999:129. Predalier A et al.; Neurology. 1972 Apr;22(4):355-65. Somerville BW.; Neurology. 2006 Sep 13: Macgregor EA et al.; Headache 2006 Oct;46 Suppl 2:S49-54. Zacur HA.

P. 71: Premarin decreases co-enzyme Q10 and vitamin gamma-E: 

Biofactors. 2005;25(1-4):61-6. Palan PR et al.

P. 72: Premarin increases stress incontinence: 

JAMA. 2005 Feb 23;293(8):935-48. Hendrix SL et al.; Menopause. 2005 Mar;12(2):160-4. Goldstein SR et al.

P. 72: Premarin increases Dry Eye Syndrome:

Gynecol Endocrinol. 2006 Sep;22(9):501-5. Uncu G et al

P. 72: Bioidentical estrogen decreases Dry Eye Syndrome:

Gynecol Endocrinol. 2005 May;20(5):289-98. Versura P et al

P. 73: Bioidentical progesterone protects from breast cancer: 

Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10506-11. Nilsen J.; J Steroid Biochem Mol Biol. 2001 Aug;78(2):185-91. McDonnel AC et al.; Clin Cancer Res. 2001 Sep;7(9):2880-6. Lin VC et al.; Am J Epidemiol. 1981;114(2):209-17 Cowan LD.; Int J Cancer. 2005 Apr10;114(3):448-54. Fournier A.; Pathol Biol. 1987;35:1081-86. Mauvais-Jarvis P.; Ann NY Acad Sci. 1986;464:152-67. Mauvais-Jarvis P.; Cancer Detect Prev. 1999;23:290-298. Plu-Bureau G.; Climacteric.2002;5:332-40. Lignieres B.; Breast Cancer Res Treat. 2006 Jul 14; Wood CE.; J Steroid Biochem Mol Biol. 2006 Oct 16; Mendelson CR.; Breast J. 2006 Nov;12(6):518-525. Kontos M.; J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):241-9. Mendelson CR et al.

P. 73: Provera and other chemicalize progestin promotes breast cancer: 

Cancer. 2003;97(6):1387. Olsson el al.; Oncogene. 2006 Dec 14;25(59):7723-39. Salatino M et al.; Breast Cancer Res Treat. 2006 Jul 14; Wood CE et al; Horm Metab Res. 2005 Aug;37(8):468-73. Seeger H et al.; BMC Cancer. 2006 Oct 18;6:246. Eigeliene N et al.; Endocrinology. 2005 Nov;146(11):4917-25. Saitoh M et al.; J National Cancer Institute. 2000;92(4):328-32. Ross RK et al; Int J Cancer. 1999;81(3):339. Magnusson C et al.; FASEB. 2007 Aug;21(10):2285-93. Birrell SN et al

P. 73: Bioidentical progesterone does not promote diabetes: 

Euro J Endo.1999;140(3):215-223. Cucinelli F et al.; Exp Physiol. 2007 Jan;92(1):241-9. Ordonez et al.

P. 73: Provera increases diabetes: Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH et al.; Am J Obstet Gynecol. 2006 Feb;194(2):355-61. Goodrow GJ et al.; Arch Intern Med. 2001;161:1766-1771. Kim C. et al

P. 73: Bioidentical progesterone builds bone: 

Endocr Res. 2003 Nov;29(4):483-501. Liang M et al.; Di Yi Jun Yi Da Xue Xue Bao. 2001;21(12):929-931. Zhang P et al.; Calcif Tissue Int. 2002 Oct;71(4):329-34. Luo XH et al.; J Tongji Med Univ. 2000;20(1):59-62. Chen L. et al.; Zhonghua Fu chan Ke Za Zhi. 1997 Sep;32(9):538-40. Chen L et al.; Zhonghua Fu chan Ke Za Zhi. 2004 Apr;39(4):250-3. Liang M et al.; Fertil Steril. 2006 Nov;86(5):1466-74. Clark MK et al.; Arch Pediatir Adolesc Med. 2005 feb;159(2):139-44. Scholes D et al.

P. 73: Provera cause bone loss: 

Menopause 2001;8(1):10-16. Montplaisir J et al.; Fertil Steril. 2004 Dec;82(6):1580-6 Clark MK et al.

P. 73: Bioidentical progesterone protects the heart: 

Arterio Thromb Vas Biol. 2001;21:243-8. Otsuki M et al.; Arterio Thromb Vas boil. 2004;24:955-961. Hermsmeyer RK et al.; J A Coll Cardiol. 2000 Dec;36(7):2154-9. Rosano GM et al.

P. 73: Provera destrucitive to the cardio vascular system and the heart: 

Circulation. 2002 Sep 24;106(13):1646-51. Sorensen MB et al.; J Am Coll Cardiol. 2000 Dec;36(7):2154-9. Rosano GM et al.; Menopause. 2006 Jan-Feb;13(1):80-6. Jeanes HL et al.; Hypertension. 2006 Nov;48(5):994-1001. Arias-Loza PA et al.; J Am Coll Cardiol. 1994 Dec;24(7):1757-61. Williams JK et al.; Steroids. 2006 Sep;71(9):834-42. Pederses DH et al.; Menopause. 2006 Jan-Feb;13(1):80-6. Jeanes HL et al.; Aterioscler Thromb Vasc. Biol. 1998 Jul;18(7):1164-71. Register TC et al.; Circulation. 2001 Oct 9;104(15)):1773-8. Wakatsuki A et al.

P. 73: Bioidentical progesterone promotes better sleep: 

Poster Endocrinology Conference. 2004 New Orlearns Callfries A.; Menopause. 2001;8(1):10-16. Montplaisir J et al.; Curr Med Chem. 2006;13(29):3575-82. Andersen ML et al.

P. 73: Provera decrease sleep quality: 

Jpn J Psychiatry Neurol. 1987 Jun;41(2):261-7. Kotorii T et al.

P. 73: Provera negative affects on the immune system: 

Virology. 2006 Aug 15;352(1):169-77. Trunova N et al.

P. 73: Provera is destructive to the brain: 

Poster Endocrinology Conference. 2004 New Orlearns Callfries A.; Endocrine. 2006 Apr;29(2):271-4. Singh M.; Gynecol Endocrinol. 2006 Jul;22(7):355-61. Nilsen J et al.

P. 73: Provera is known to induce neuron-degenerative diseases: 

Gynecol Endocrinol. 2006 Jul;22(7):355-61. Nilsen J.; J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):205-13. Pluchino N et al.; Proc Natl Acad Sci USA. 2003 Sep 2;100(18):10506-11. Nilsen J et al.; J Neurobiol. 2006 Aug;66(9):916-28. Ciriza I et al.

P. 73: Bioidentical progesterone protects neurological system: 

J Neurobiol. 2006 Aug;66(9):916-28. Ciriza I et al.; Endocrine. 2006 Apr;29(2):271-4. Singh M.; J Neurotrauma. 2006 Feb;23(2):181-92. Labombarda F et al.; J Neuroendocrinol. 2004 Jan;161(1):58-63. Ciriza I et al.; Neuro Endocrinol Lett. 2006 Oct;27(5):675-8. Muller E et al.; Pharmacol Biochem Behav. 2006 Jul;84(3):420-8. Cutler SM et al.; J Mol Neurosci. 2006;28(1):3-15. De Nicola AF et al.; J Neurosci Res. 2007 Aug 15;85(11):2441-9. Kaur P et al.; Exp Neurol. 2007 Feb;203(2):406-14. Gonzalez Deniselle MC et al.

P. 73: Provera promotes aggressive feelings: 

Pharmacol Biochem Behav. 2006 Jul;84(3):420-8. Cutler SM et al.

P. 73: Provera promotes anxiety and depression: 

J Women’s Health Gend Base Med. 2000 May;9(4):381-387. Fitzpatrick LA et al.

P. 74: Provera increases seizures: 

Epilepsia. 2006 Sep;47(9):1447-51. Harden CL et al.

P. 74: Bioidentical progesterone increases GABA and allopregnenolone and is a brain calmer: 

J Neuro Endocrinol. 1995 Mar;7(3):171-7. Bitrn D.; Brain Res. 1995 May 22;680(1-2):135-41. Picazo O et al.; J Women’s Health Gend Base Med. 2000 May;9(4):381-7. Fitzpatrick LA et al.; J Neuroendocrinol. 2004 Jan;161(1):58-63. Ciriza I et al.

P. 74: Provera negatively affects hearing: 

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14246-9. Guimaraes P et al.

P. 73: Bioidentical progesterone has a positive affect on hearing: 

Neuropsychologia. 2002;40(8):1293-9. Alexander GM et al.

P.74: Provera may promote allergy, IBS and IC by increasing mast cells: 

Hum Reprod. 2000 Jan;15(1):123-30. Vincent AJ et al.

P. 74 Bioidentical progesterone decreases mast cells: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.

P. 74 Bioidentical progesterone decreases water retention: 

Horm Metab Res. 2004 Jun;36(6):381-6. Quinkler M et al.

P. 74: The scientific community is aware of the significant dangers associated with provera use: 

Menopause. 2001;8(1):10-16. Montplaisir J et al.; Cancer. 2003;97(6):1387-92. Olsson HL et al.; J A Coll Cardiol. 2000 Dec;36(7):2154-9. Rosano GM et al.; Epilepsia. 2006 Sep;47(9):1447-51. Harden CL et al.; Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14246-9. Guimaraes P et al.; Endocrine. 2006 Apr;29(2):271-4. Singh M.; Menopause. 2006 Jan-Feb;13(1):80-6. Jeanes HL et al.; Oncogene. 2006 Dec 14;25(59):7723-39. Salatino M et al.; Gynecol Endocrinol. 2006 Jul;22(7):355-61. Nilsen J et al.; J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):205-13. Pluchino N et al.; Hypertension. 2006 Nov;48(5):994-1001. Arias-Loza PA et al.; Fertil Steril. 2004 Dec;82(6):1580-6. Clark MK et al.; Fertil Steril. 2006 Nov;86(5):1466-74. Clark MK et al.; Horm Metab Res. 2005 Aug;37(8):468-73. Seeger H et al.; BMC Cancer. 2006 Oct 18;6:246. Eigeliene N et al.; Endocrinology. 2005 Nov;146(11):4917-25. Saitoh M et al.; Hum Reprod. 2000 Jan;15(1):123-30. Vincent AJ et al.; J National Cancer Institute. 2000 Feb 16;92(4):328-32. Ross RK et al.; Int J Cancer. 1999;81(3):339. Magnusson C.; Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH.; Ann Clinic Biochem. 1996 May;33(Pt 3):187-9. Malik KJ et al.; Sex Transm Dis. 2004 Sep;31(9):561-7. Morrison CS et at.; Arch Pediatr Adolesc Med. 2005 Feb;159(2):139-44. Scholes D et al.; Acta Obstet Gynecol Scand. 2004 Oct;83(10):909-11. Ziaei S et al.; Virology. 2006 Aug 15;352(1):169-77. Trunova N et al.; AIDS. 2004 Jan 23;18(2):205-9. Wang CC et al.; J Infect Dis. 1998 Oct;178(4):1053-9. Martin HL Jr et al.

P. 79: Dairy products have higher levels of estrogen than currently recognized: 

J Agric Food Chem. 2006 Dec 27;54(26):9785-91. Malekinejad H et al.
P. 71: Report of significant early decline in testosterone levels in men: 

J Endocrinol & Metab. 2007 Jan;92(1)44-45. Travison TG et al.
P. 84: Low levels of estrogen associated with decrease in vascular tone: 

Ob Gyn News April 15 2005. Wkdman RP. Swan study
P. 84: Low levels of estrogen associated with increase in arterial sclerosis: 

Fertil Steril. 2004:82:391-7. Mack WY et al.
P. 84: Low levels of estrogen associated with increase incidence of heart attack and stroke: 

Ann NY Acad Sci. 1990;592:193-203. Stampfer MJ et al.
P. 84: Estrogen replacement associated with decrease of 60% in aortal calcification: 

NEJM 2007 Jun;356:259-602. Manson JA et al.
P. 84: Reasons women should be focused on maintaining natural estrogen levels: 

Am J Obstet Gynecol. 1967;99:155-62. Parrish H et al.
P. 84: Estradiol prevents thickening of heart walls: 

Br Med J. 1989;298:642-4. Witterman J et al.
P. 84: Estradiol prevents heart failure: 

Basic Res Cardiol. 2006 Jul 4; Beer S et al.
P. 84: Estradiol prevents thickening of heart walls: 

Nucl Recept Signal. 2006;4:e013. Kim JK et al.
P. 84: Estradiol treatment decreases fibrinogen: 

Menopause. 2006 Jul-Aug;13(4):643-50. Zegura B et al.
P. 85: Estradiol lowers homocysteine: 

Menopause. 2001 Jul-Aug:8(4):252-8. Ventura P et al.
P. 85 Estradiol decreases the thickening of the carotid artery walls: 

Hypertens Res. 2005 Jul;28(7):579-84. Sumino H et al.
P. 85: WHI study causes recommendation to stop supplementing all hormones fail to distinguish between bioidentical and chemicalized estrogens: 

JAMA. 2002;288:321-333. Women’s Health Initiative (WHI Study) et al.
P. 86: Estradiol alone in the presence of arterial sclerosis will exacerbate this condition: 

J Clin Endocrinol Metab. 2006 Dec;91(12):4995-5001. Seli E et al.
P. 86: The medical community started to understand the toxic effect of HRT and the more beneficial affect of natural HRT on the cardiovascular system: 

Expert Rev Cardiovasc Ther. 2007 Jul;5(4):777-89. Koledova VV et al.
P. 86: Cholesterol metabolite 27 hydroxycholesterol inhibit the cardiovascular protection of estrogen: 

Nat Med. 2007 Sep 16;Umetani M et al.
P. 86: Bioidentical progesterone decreases apatosis and downregulates Fas and Fas expression: 

Biol Reprod. 2004 Dec;71(6):2065-71. Okuda K et al.; Febs Lett. 2000 Jan 28;466(2-3):279-82. Kuranaga E et al.
P. 86: Bioidentical estradiol applied to skin increases adiponectin: 

Fertil Steril. 2006 Dec;86(6)1669. Chu MC.
P. 86: Ghrelin causes cravings and increases hunger: 

Physiol Behav. 2006 Aug 30;89(1):71-84. Cummings DE.
P. 87: Bioidentical estradiol applied to skin decreases ghrelin: 

Fertil Steril. 2006
Dec;86(6)1669. Micheline CC et al.
P. 87: Bioidentical estradiol increases CCK, satiety, and decreases food intake: 

Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1251-63. Asarian L et al.
P. 87 Decline of estrogen leads to binge-eating: 

Psychol Med. 2006 Oct 12;:1-11. Edler C et al.
P. 87: Prolonged estradiol treatment increases insulin sensitivity: 

Mol Endocrinol. 2006 Jun;20(6):1287-99. Gao H et al.
P. 87 Premarin increases body fat and decreases lean body mass: 

Adv Ther. 2006 Mar-Apr;23(2):263-73. Delibasi T et al.
P. 87: Bioidentical estradiol cream is more effective in managing weight and insulin sensitivity than capsule form: 

Fertil Steril. 2006 Dec;86(6)1669. Micheline CC et al.
P. 87: Estrogen behaves like an antioxidant: 

Swiss Med Wkly. 2006 Aug 5;136(31-32):510-4. Delibasi T et al.
P. 87: Estradiol decreases IL-6: Gynecol Obstet Mex. 2006 Mar;74(3): 

133-8. Saucedo Garcia R et al.; J HuazhongUniv Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
P. 87: Estradiol decreases NF-?B: Cytokine. 2005 Aug 21;31(4):

251-7. Liu H et al.; J HuazhongUniv Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
P. 88: Failing to maintain estrogen levels may cause permanent memory loss: 

J Neuroendocrinol. 2007 Feb;19(2):77-81. Sherwin BB.
P. 89: Estrogen decreases chronic hepatitis fibrosis via antioxidant effect: 

Braz J Infect Dis. 2007 Jun;11(3):371-4. Codes L et al.
P. 89: Scientific data on the benefits of estrogen beyond reproductive function: 

Endo Reviews. 2005 26(3):308-312. Wise PM et al.
P. 89: Estrogen improves levels of Acetylcholine: 

Brain Res. 2000;864(2):263-69. Farr SA et al.
P. 89: Estrogen improves levels of serotonin: 

Psychopharmacol Bull. 1997;33(2):229-33. Chakravortv SG et al.; Life Sci. 1998;63(3):155-60. Holschneider DP et al.; Endocrinology. 2002 Oct;143(10):3974-83. Temels S et al.
P. 89: Estrogen enhances norepinephrine function: 

Endocrinology. 2002 Oct;143(10):3974-83. Temel S et al.
P. 89: LH increase as sign of estrogen decline and associated with cognitive decline: 

Mol Cell Endocrinol. 2007 apr 15;269(1-2):107-11. Casadesus G. et al.
P. 89: Estrogen increases executive function and cognitive function: 

Horm Behav. 2006 Dec 13; Norbury R et al.
P. 89: Estrogen increases verbal memory: 

Ann N Y Acad Sci. 2005 Jun;1052:3-10. Sherwin BB.
P. 89: Estrogen increases cognitive recognition: 

Women Health. 2006;43(1):37-57. Stephens C et al..
P. 89: Estrogen increases spatial memory: 

Neurobiol Aging. 2006 Apr 16; Harburger LL et al.; Women Health. 2006;43(1):37-57. Stephens C. et al.
P. 89: Estrogen increases BDNF: 

Front Neuroendocrinol. 2006 Oct 19; Scharfman HE et al.
P. 90: Estrogen prevents brain grey matter loss: 

Menopause. 2006 Jul-Aug;13(4):584-91. Boccardi M et al.
P. 90: Estrogen prevents brain white matter loss: 

Neurobiol Aging. 2006 Oct 6; Ha DM et al.
P. 90: Estrogen protects against Alzheimer’s Disease: 

Adv Etp Meg Bio. 1997;429:261-71. Chang D et al.; Menopause. 2006 Jul-Aug;13(4):584-91. Boccardi M et al.
P. 90: Estrogen protects against injury from stroke: 

Trends Neurosci. 2001 Jul;24(7):386-91. Stein DG.
P. 90: Estrogen protects against injury from epilepsy: 

Neuroscientist. 2007 Feb;13(1):77-88. Veliskova J.
P. 90: Estrogen protects against stress-induced damage to hippocampal calls: 

Neuroscience. 2007 Feb 21; Takuma K et al.
P. 90: Low levels of estrogen in beginning of woman’s cycle are associated with depression: 

Arch Gen Psychiatry. 2000 Dec;57(12):1157-62. Young EA et al.
P. 90: Women in peri-meopause experience greater incidence of depression: 

North American Menopause Society 2007. Schmidt PJ et al.
P. 90: Depressed women enter menopause earlier: 

Arch Gen Psychiatry. 2001 June;58(6):529-34. Soares CN et al.
P. 90: Estrogen improves mood, decrease post partum depression and anxiety: 

Psychoneuroendocrinology. 2007 May;32(4):350-7. Hill MN et al
P. 91: Postpartum depression and psychosis successfully treated with estrogen: 

J Clin Psychiatry. 2000 Mar;61(3):166-9. Ahokcas A et al.
P. 91: Non-responsive depression successfully treated with estradiol: 

Arch Gen Psychiatry.. 1997 May;36(5):550-4. Klaiber EL et al.
P. 91: Depressed peri-menopausal women who do not respond to SSRI after administration of estrogen improve their mood: 

J Clin Psychiatry. 2002;63 Suppl 7:45-8. Rasgon NL et al.
P. 91: Estrogen acts as an MOA Inhibitor: 

Psychopharmacol Bull. 1997;33(2):229-33. Chakravortv SG et al.; Life Sci. 1998;63(3):155-60. Holschneider DP et al.
P. 91: Estrogen improves production of Serotonin and Norepinephrine: 

Brain Res. 2000;864(2):263-69. Farr SA et al.
P. 92: Bioidentical estrogen has a significant positive effect on panic attacks: 

Orv Hetil. 2006 May 14;147(19):879-85. Magyar Z et al.; J Affect Disord. 2001 Oct;66(2-3):273-9. McManus K et al.; J Clin Psychiatry. 1995 Nov;56(11):533. Chung CK et al.
P. 94: Migraines are more frequent on days estrogen levels decline: 

Headache. 2006 Oct;46 Suppl 2:S49-54. Zacur HA.
P. 94: Migraines less frequent on days estrogen levels rise: 

Neurology. 2006 Sep 13: Macgregor EA et al.; Neurology. 1991 Jun;41(6):786-93. Silberstein SD et al.
P. 94: Migraines less common in pregnancy: CNS Drugs. 2006;20(2):

125-41. Ashkenazi A et al.
P. 94: Migraines are more frequent when estrogen levels drop: 

Headache. 1978;17:250. Ryan et al.
P. 94: Migraines more frequent immediately after delivery: 

Neurology. 1972;22:355. Somerville et al.; CNS Drugs. 2006;20(2):125-41. Ashkenazi A et al.
P. 94: Relationship between migraines and changing levels of estrogen: 

Neurology. 2006 Sep 13: Macgregor EA et al.
P. 94: "Menstrual migraines are due to low level of estrogen": 

Neurology. 1991 Jun;41(6):786-93. Silberstein SD et al.; The Female Patient. 2006 Sept;31 12-20. Rozen T.
P. 95: Bioidentical estrogen causes brighter appearance, rounder, fuller, rosier lips: 

Proc Biol Sci. 2006 Jan 22;273(1583):135-40. Smith MJ et al.
95: Bioidentical estradiol and estriol cream increases elasticity firmness, decreases wrinkle depth and pore size of the skin: 

Int J Dermatol. 1996 Sep;35(9):669-74. Schmidt JB et al.; Climacteric. 2007 Aug;10(4):289-97. Verdier-Sevrain S.
P. 95: Estrogen treatment improves visual function: 

Meno. 2003;10(1)53. Guaschimo S et al.
P. 95: Estrogen treatment prevents intraocular pressure and improves amount/quality of eye lubrication: 

Ophthalmologica. 2004 Mar-Apr;218(2):120-9. Altintas O et al.
P. 95: Premarin is associated with higher incidents of Dry Eye Syndrome:
Gynecol Endocrinol. 2006 Sep;22(9):501-5. Uncu G et al
P. 95: Estrogen deficiency is associated with age-related hearing loss: 

Amer J. Ob/Gyn.2004 Jan;190(1):77-82. Kilicdag EB et al.
P. 95: Estrogen help muscle development and healing rates: 

J Appl Physiol. 2006 Jun;100(6):2012-23. McClung JM et al.
P. 95: Estrogen decreases incidents of duodenal stress ulcers: 

Am J Physiol Gastrointest Liver Physiol. 2006 Oct5; Shimozawa N et al.
P. 96: Estrogen decrease gastric cancer due to H Pylori bacteria: 

Carcinogenesis. 2007 Aug 27; Ohtani M et al.
P. 96: Estrogen promotes energy; particularly in women with CFS: 

J Clin Pathol. 2006 May 26; Grans H et al et al.
P. 97: Protective effects of estriol established more than 35 years ago: 

Ann Intern Med. 1978 Sep;89(3):422-3. Lemon HM.
P. 97: Estriol restores vaginal integrity: JAMA. 1978 Apr 21;239(16):

1638-41. Tzingounis VA et al.; J Med Assoc Thai. 2001 Apr;84(4):539-44. Manonai J et al.
P. 97: Estriol does not promote uterine tissue growth which may decrease the incidence of uterine cancer: 

Comp Biochem Physiol C. 1990;96(2):241-4. Tamaya T et al.; JAMA. 1978 Apr 21;239(16):1638-41. Tzingounis VA et al.
P. 97: Estriol quickly alleviates night sweats and hot flashes: 

JAMA. 1978 Apr 21;239(16):1638-41. Tzingounis VA et al.; Zhonghua Yi Xue Za Zhi (Taipei). 1995 May;55(5):386-91. Yang TS et al.; Maturitas. 2000 Feb 15;34(2):169-77. Takahashi K et al.
P. 97: Estriol has decreases NFkB: J Neuroimmunol. 2002 Mar;124(1-2):

106-14. Zang YC et al.
P. 97: Estriol reduce coronay hyperactivity: 

Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H295-303. Mishra RG et. al
P. 97: Estriol decreases TNF-a: J Immunol. 2003 Dec 1;171(11):

6267-74. Soldan SS et al.
P. 97: Estriol may help build bone: 

Gynecol Endocrinol. 2003 Dec;17(6):455-61. Yamanaka Y et al
P. 97 UCLA study of bioidentical estriol in the treatment of MS: 

Neurology. 1999 Apr 12;52(6):1230-8. Kim S et al.; J Immunol. 2003 Dec 1;171(11):6267-74. Soldan SS et al.; Ann Neurol. 2002 Oct;52(4):421-8. Sicotte NL et al.
P. 98: Estrogen beta receptor deficiency may cause interstitial cystitis: 

Proc Natl Acad Sci USA. 2007 Jun 5;104(23):9806-9. Imamov O et al.; J Endocrinol. 2007 June;193(3):421-33. Treeck O et al.
P. 98: Estriol affects beta receptors that decrease breast tissue proliferation: 

Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.; Endocrinology. 2007;148(2):538-547. Cvoro A et al.
P. 98: Estriol prevents breast cancer cells from producing new blood vessels and VEGF: 

Cancer Res. 2006 Dec 1;66(23):11207-13. Hartman J et al.
P. 98: Estriol has anti tumor effect on ovarian cancer cell: 

J Endo Crinol. 2007 Jun;193(3):421-33. Treeck O et al.
P. 105: Estridol patch delivers unpredictable amounts of estrogen: 

Fertil Steril. 2003 Mar;79(3):534-42. Kraemer GR et al.
P. 107: Low-dose Estradiol patch provides too little to benefit cognitive function: 

Arch Neurol. 2006 Jul;63(7):945-50. Yaffe K et al.
P. 107: Intermittent dosing of estrogen impairs cognition: 

Brain Res. 2006 Oct 18;1115(1):135-47. Gresack JE et al.
P. 108: Studies indicate birth control pills cause decline in cognition: 

J Nerv Ment Dis. 1999 May;187(5):275-80. Rubino-Watkins MF et al.

P. 112: Balancing effect of estrogen by progesterone important for preventing development of cancer: 

J Clinc Endo Metab. 2002;87(1):3-15. Hale et al.; Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14021-6. Pan H et al.
P. 112: Progesterone blocks UroKinase Pasminogen Activator and protect breat cancer proliferation: 

J Steroid Biochem Mol Biol. 2001 Aug;78(2):185. McDonnel et al.; Clin Cancer Res. 2001 Sep;7(9):2880. Lin V et al.
P. 113: Progesterone blocks NF-KBeta and Cox-2 and protect breast cancer: 

J Steroid Biochem Mol Biol. 2006 Oct 16; Mendelson CR et al.
P. 113: Progesterone protects breast tissue from HER 2/new oncogene: 

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):241-9. Mendelson CR et al.
P. 113: Study showing that cancer biomarkers increased in primate group taking Provera while not in group taking progesterone: 

Breast Cancer Res Treat. 2007 Jan;101(2):125-34. Wood CE et al.
P. 113: Women who are operated on to remove breast cancer during cycles when progesterone present enjoy increased survival rate: 

Breast J. 2006 Nov;12(6):518-525. Kontos M et al.
P. 113: Use of bioidentical progesterone cream on breasts to decrease benign and overall incidence of breast cancer: 

Cancer Detect Prev. 1999;23:290-298. Plu-Bureau G et al.
P. 114: Johns Hopkins study of significant increase mortality, cancer, and breast cancer in women who had low progesterone vs. normal progesterone: 

Am J Epidemiol. 1981;114(2):209-17 Cowan LD et al.
P. 114: French study showing increase in breast cancer for women using chemical progesterone and decrease for those who used bioidentical progesterone: 

Int J Cancer. 2005 Apr10;114(3):448-54. Fournier A et al.
P. 114: Study showing women who used no hormones (vs. those using bioidentical progesterone and estrogen) increase in breast cancer: 

Gynecol Endocrinol. 2006 Aug;22(8):423-431 Espie M et al.
P. 115: Progesterone inhibits VCAM-1: 

Arterio Thromb Vas Biol. 2001;21:243-8. Otsuki M et al.

P. 115: Progesterone promotes the function and maintenance of brain: 

J Neurobiol. 2006 Aug;66(9):916-28. Ciriza I et al.; Endocrine. 2006 Apr;29(2):271-4. Singh M.
P. 115: Progesterone increases myelin: 

J Neurotrauma. 2006 Feb;23(2):181-92. Labombarda F et al.
P. 115: Progesterone significantly aids in decreasing brain edema: 

Pharmacol Biochem Behav. 2006 Jul;84(3):420-8. Cutler SM et al 

P. 115: Progesterone increases production of GABA: 

J Neuro Endocrinol. 1995 Mar;7(3):171-7. Bitrn D.; Brain Res. 1995 May 22;680(1-2):135-41. Picazo O et al.; Psychopharmacology (Berl). 2006 Jun;186(3):312-22. Frye CA et al.: J. Women’s health Gend Base Med. 2000 May;9(4):381-7. Fitzpatrick LA et al.
P. 115: Progesteron increase BDNF and decrease glutamate toxicity: 

J Neurosci Res. 2007 Aug 15;85(11):2441-9. Kaur P et al.
P. 116: Women given Provera for five years and switched to bioidentical progesterone for 6 months improve mood, decreased anxiety and depression: 

J Women’s Health Gend Base Med. 2000 May;9(4):381-7. Fitzpatrick LA et al.
P. 116: Progesterone helps you to fall a sleep and maintain your sleep: 

Poster Endocrinology Conference. 2004 New Orlearns Callfries A.; Menopause. 2001;8(1):10-16. Montplaisir J et al.; Curr Med Chem. 2006;13(29):3575-82. Andersen ML et al.
P. 116: Progesterone improves immunity: 

J Cell Biochem. 2006 Sep 1;99(1):292-304. Chien EJ et al.
P. 116: Progesterone builds bones: 

Zhonghua Fu chan Ke Za Zhi. 1997 Sep;32(9):538-40. Chen L et al.; Zhonghua Fu chan Ke Za Zhi. 2004 Apr;39(4):250-3. Liang M et al
P. 117: Progesterone improves hearing: 

Neuropsychologia. 2002;40(8):1293-9. Alexander GM et al. 

P. 117: Progesterone protects from seizures: 

J Neuro Endocrinol. 1995 Mar;7(3):171-7. Bitrn D et al.; Brain Res. 1995 May 22;680(1-2):135-41. Picaso O et al.; Brain Res. 2006 Jul 26;1101(1):110-6. Lonsdale D et al.; Neurosci Lett. 2007 Jan 10;411(2):147-51. Lonsdale D et al.
P. 117: Progesterone decreases allergies: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.
P. 117: Progesterone decreases IBS: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.
P. 117: Progesterone decreases Interstitial Cystitis: 

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):787-94. Vasiadi M et al.
P. 117: Progesterone prevents and resolves water retention: 

Horm Metab Res. 2004 Jun;36(6):381-6. Quinkler M et al.
P. 117: Progesterone a strong antagonist of Aldosterone: 

Horm Metab Res. 2004 Jun;36(6):381-6. Quinkler M et al
P. 117: Progesterone decrease cocain craving: 

Exp Clin Psychopharmacol. 2007 Oct;15(5):472-80. Anker JJ et al.
P. 123: Studies show women with PMS have low levels of progesterone and allopregnenolone: 

Obstet Gynecol. 1997 Nov:90(5):709-14. Rapkin AJ et al.; Eur J Endocrinol. 2000 Mar;142(3):269-73. Monteleone P et al.
P. 123: Article showing benefit of supplementing bioidentical estrogen in PMS: 

Br J Obstet Gynaecol. 1995 Jun;102(6):475-84. Smith RN et al.
P. 123: Decreased levels of estrogen causation of PMS: 

J Br Menopause Soc. 2004 Dec;10(4):151-6. Hassan I et al.; Psychol Med. 2006 Jul;36(7):901-12. Saunders KE et al.
P. 125: Supplementing absorbable Magnesium benefits women with PMS: 

Obstet Gynecol. 1991 Aug;78(2):177-81. Facchinetti F et al.; Clin Drug Investig. 2007;27(1):51-8. Quaranta S et al.
P. 125: Magnesium Oxide does not resolve PMS: 

J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. De Souza MC et al.
P. 125: Vitamin B6 shown to provide moderate benefits in PMS: 

J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. De Souza MC et al.; J R Coll gen Pract. 1989 Sep;39(326):364-8. Doll H et al.
P. 126: Studies indicate physical activity can relieve many discomforts of PMS: 

Women Health. 2004;39(3):35-44. Lustyk MK et al.
P. 126: Vaginal Progesterone cream thins the uterine lining and decreases fertility: 

Fertil Steril. 1999 Nov;72(5):830-6. Dumario MA et al.
P. 126: Endometriosis occurs when an increase of oxidative stress and the presence of free radicals: 

Hum Reprod. 2005 Jul;20(7):2014-20. Jackson LW et al.; J Soc Gynecol Investig. 2006 Sep;13(6):390-8. Alpay Z et al.
P. 126: Endometriosis occurs with an increase of aromatization: 

Endocr Relat Cancer. 1999 Jun;6(2):293-301. Bulun SE et al.; Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):144-50. Ebert AD et al.; Semin Reprod Med. 2004 Feb;22(1):45-50. Bulun SE et al.; Hum Reprod Updae. 2006 Jan-Feb;12(1):49-56. Attar E et al.; Fertil and Steril. 1999 Dec;72(6):961-1106. Khaled M et al.
P. 126: Endometriosis occurs with an increase in inflammation: 

Fertil Steril. 2005 May;83(5):1530-5. Horie S et al.; Fértil Steril. 2004 Oct;82 Suppl 3:1023-8. Yamauchi N et al.; Fertil Steril. 2005 Mar;83(3):529-37. Osteen KG et al.; Am J Reprod Immunol. 2006 Oct;56(4):267-74. Kitawaki J et al.
P. 126: Endometriosis occurs with a compromised immune system: 

Biol Reprod 2005 Sep;73(3):565-70. Cao WG et al.; Fertil and Steil. 2006;86(5):1336- Anaf V et al.
P. 126: Relieving stress will decrease inflammation: 

Neurol Clin. 2006 Aug;24(3):483-91. Avitsur R et al.
P. 126: Relieving depression decrease inflammation: 

Arch Intern Med. 2007 Jan 22;167(2):174-81. Ranjit N et al.; Psychosom Med. 2006 Jul-Aug;68(4):538-46. Taylor CB et al.
P. 126: Physical activity will restore body’s control over inflammation: 

J Physiol Pharmacol. 2006 Nov;57 Suppl 10:43-51. Petersen AM et al.; Essays Biochem. 2006;42:105-17. Pedersen BK et al.
P. 126: Bioidentical progesterone resolves root causes of Endometriosis: 

J Steroid Biochem Mol Biol. 2006 Oct 16; Mendelson CR et al.; Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14021-6. Pan H et al.; Fertil and Steil. 2006;86(5):1336- Anaf V et al.; Fertil Steril. 2005 May;83(5):1530-5. Horie S et al.; Fertil Steril. 2004 Oct;82(3):1023-8. Yamauchi N et at.
P. 128: Depo-Provera causes weight gain: 

Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH et al.
P. 128: Depo-Provera increases incidence of bladder infections: 

Acta Obstet Gynecol Scand. 2004 Oct;83(10):909-11. Ziaei S et al.
P. 128: Depo-Provera increases incidence of diabetes: 

Diabetes Care. 2006 Mar;29(3):613-7. Xiang AH et al.
P. 128: Depo-Provera increases risk of Chlamydia and Gonorrhea infection: 

Sex Transm Dis. 2004 Sep;31(9):561-7. Morrison CS et al.
P. 128: Depo-Provera increases rate of acquisition of HIV infection: 

J Infect Dis. 1998 Oct;178(4):1053-9. Martin HL Jr et al.
P. 128: Depo-Provera increases ability to infect others with HIV: 

AIDS. 2004 Jan 23;18(2):205-9. Wang CC et al.
P. 128: Depo provera increases milk production in not pregnant users: 

Scientific World Journal. 2006 May 5;6:538-41. Omar HA et al.

P. 138: HGH treatment decreases cholesterol, triglycerides, and fibrinogen levels: 

Clin Endocrinol. (Oxf) 2006 Apr;64(4):444-9. Ahn CW et al.; Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7. Nam SY et al.
P. 132: HGH prevents and slows progression of arterial schlerosis: 

J Clin Endo Metab. 2005 Apr;90(4):2056-62. Colao A et al.; J Clin Endo Metab. 2005 May;90(7):3978-82. Lanes R et al.
P. 132: HGH improves condition of women with chronic heart failure: 

J Clin Endocrinol Metab. 2006 Oct 24; Lecorvosier P et al.; Horm Metab Res. 2006 Oct;38(10):656-61. Wallaschofski H et al.
P. 132: HGH improves bone density by increasing amylin levels: 

J Of Cell Biology. 2004 Feb;164(4):509-14. Dacquin R et al.
P. 132: HGH treatment improves bone density in hips: 

J Endocrinol Invest. 2005;28(8SUPPL):32-6. Agnusdei D et al.; Curr Pharm Des. 2002;8(23):2023-32. Svensson J.
P. 133: HGH treatment improves growth of bone in spine: 

Curr Pharm Des. 2002;8(23):2023-32. Svensson J.
P. 133: HGH burns omental, trunk and visceral fat that surrounds internal organs: 

Growth Horm IGF Res. 2006 Nov 20; Albert SG et al.; Horm Metab Res. 2005 Jan;37(1):49-52. Herrmann BL et al.; Curr Med Res Opin. 2006 Oct;22(10):1973-9. Chihara K et al.; Clin Endocrinol. (Oxf) 2006 Apr;64(4):444-9. Ahn CW et al.; Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7. Nam SY et al.
P. 133: Children with low levels of HGH also have low adiponectin: 

J Pediatr. 2006 Sep;149(3):324-9. Lanes R et al.
P. 134: HGH improves capacity to exercise: 

Am J Cardiol. 2006 Apr 1;97(7):1097-102. Climent VE et al.
P. 134: Natural HGH rises when young adults exercise: 

Horm Res. 2006;56(2):57-61. Stokes K.
P. 134: When young adults exercise in the cold weather HGH levels does not increase: 

Growth Horm IGF Res. 2006 Apr;16(2):125-31. Wheldon A et al.
P. 134 When older adult exercise they do not increase their HGH levels: 

Horm Res. 2006;65(2):57-61. Stokes K et al.
P. 134: Women with low HGH levels do not sleep well: 

Neuroendocrinology. 1990 Jan;51(1):82-4. Astrom C et al.
P. 134: HGH treatment helps women to sleep: 

Clin Endocrinology. (Oxf) 1990 Oct;33(4):495-500. Astrom C et al.
P. 134: If women with severe HGH deficiencies are taken off HGH they experience psychological deterioration. 

Clin Endocrinol. (Oxf) 2003 Oct;59(4):467-75. McMillan CV et al.
P. 135: HGH has positive affect on brain fuction: 

Endocrin Reviews. 2005 Dec;26(7):916-943. Russo V.C et al.
P: 135: HGH improves quality of life: 

J. Clin Endocrinol Metab 2006 May;91(5):1621-34. Molitch ME et al.
P. 135: Higher levels of HGH associated with faster and more effective recovery from stroke: 

J Clin Endocrinol Metab. 2006 Oct;91(10):3928-34. Bondanelli M et al.
P. 135: Supplementation of HGH does not decrease body’s production of HGH: 

J Clin Endo Crinol Metab. 1990 Jun;70(6):1612-5. Wu RH et al.
P. 135: HGH improves ovarian function: 

Eur J Endocrinol. 1996 Feb;134(2):190-6. Bergh C et al.
P. 136: HGH promotes fertility by participating in ovarian follicle development: 

Fertil S:teril. 1996 Dec;66(6):948-53. Lanzone A et al.
P. 136: HGH improves response to Clomid: 

Fertil Steril. 2000 Jan;73(1):78-84. Rossato P et al.
P. 136: HGH improves response to in vitro fertilization: 

Med Hypotheses.1997 Nov;49(5):413-5. Orvieto R et al.; Gynecol Endocrinol. 1991 Mar;5(1):33-6. Homburg R et al.
P. 136: HGH improves every aspect of reproduction: 

Clini Endo Meta. 1990 Jun;70(6):1612-5. Wu RH et al.
P. 136: HGH improves energy in women with Fibromyalgia: 

Am J Med. 1998;104(3):227-31. Bennett RM et al.
P. 136: HGH should always be considered for anemic women: 

J Endocrinol Inves. 2006 May;29(5):399-404. Bergamaschi S et al.
P. 136: HGH has significant benefit with every aspect of skin function: 

J Orthop Res. 2002 Sep;20(5):910-919. Dahlgren LA et al.
P. 137: Burn victims have a lower mortality rate when treated with HGH: 

Zhonghua Shao Shang Za Zhi 2005 Oct;21(5):347-9. Chen GX et al.
P. 140: HGH shown to support and reinforce the immune system: 

J Clin Endocrin Metab.1997 Nov;82(11):3590-6. Khorram O et al.
P. 140: HGH increases monocyst: J Clin Endocrin Metab.1999 Jan;84(1):58-63. Serri O et al.
P. 140: HGH increases Glutathion, decreases NF-Kappa Beta and help cell survival: 

Br J Cancer. 2003 Sep15;89(6):1108-15. Cherbonnier C et al.
P. 141: HGH increases Natural Killer cells: 

Metabolism. 1990 Dec;39(12):1320-4. Crist DM et al.
P. 141: Mice with stomach cancer treated with HGH has reduction in cancer progress: 

World J Gastroenterol. 2006 Jun 28;12(24):3810-3. Liang DM et al.
P. 141 HGH increases IGBP3 and IGBP3 decreases the incidence of breast cancer: 

Biochem Biophys Res Commen. 1994 Jan 14;198(1):292-7. Pratt SE et al.; J Clin Endocrin Metab 2002;87(12):5722-29. Zeleznik AJ et al.
P. 141: HGH increases EPO secretion: 

Eur J Encocrinol. 1998 Mar;138(3):302-6. Sohmiya M et al.
P. 141: HGH builds cancer-fighting white cells: 

Eur j Endocrinol. 2005 Feb;152(2):211-5. Sohmiya M et al.
P: 141: HGH builds lymphocytes: 

Endo Rev. 1997 Apr;18(2):157-179. Clark R et al.
P. 141: HGH increases adiponectin which protects the body from breast cancer: 

J Clin Endocrinol Metab. 2003 Nov;88(11):5193-8. Eden Engstrom B et al.
P. 141: Adiponectin prevents development of new blood vessels by cancer cells: 

Proc Natl Acad Sci USA. 2004;101(8):2476-81. Brakenhelm E et al.
P. 141: HGH reverses bone marrow deterioration: 

Endocrinology. 2002 Feb;143(2):690-699. French R.A et al.
P: 141: HGH does not promote cancer in adult or children: 

J Clinic Endocrinol Metab. 2001;86(5)1868-70 Consensus Statement HGH Research Society.; Clin Endocrinol (Oxf). 2006 Feb;64(2):115-21. Jenkins PJ et al.
P. 141: Children with brain tumors subsequently treated with HGH show no increase in formation of new tumors: Clin Endocrinol. (OXF) 2006 Feb;64(2):115-21. Jenkins PJ et al.
P. 141: Acromegalic adults are not representative of healthy adults who supplement HGH: 

Clin Endocrinol. (OXF) 2006 Feb;64(2):115-21. Jenkins PJ et al.
P. 141: HGH can decrease apatosis in patients with colon cancer: 

Endocrinolgy. 2004 Jul;145(7):3353-62. Bogazzi F et al.
P. 141: In other cancer cells HGH increases apatosis by increasing Glutathione and may be cancer protective: 

Br J Cancer. 2003 Sep15;89(6):1108-15. Cherbonnier C et al.
P. 141: "… extensive data to date… indicates that… growth hormone is safe.": 

J Clinic Endocrinol Metab. 2001;86(5):1868-70. Consensus Statement Hgh Research Society.
P. 142: HGH may improve chemotherapy response: 

Cancer Gene Therapy. 2002 Jun;9(6):497-504. Cherbonnier C et al.
P. 142: HGH improves gastric cancer treatment: 

World J Gastroenterol. 2004 Apr 15;10(8):1132-6. Chen JY et al.; World J Gastroenterol. 2006 Jun 28;12(24):3810-3. Liang DM et al.
P. 142: HGH counteracts bone marrow suppression during chemotherapy: 

Blood. 1992 Sep 15;80(6):1443-7. Murphy WJ et al.; Endocr Rev. 1997 Apr;18(2):157-79. Clark R.; Endocrinology. 2002 feb;143(2):690-9. French RA et al.
P. 142: HGh treatment administered to diabetic obese patients improve insulin sensitivity: 

Clin Endocrinol. (Oxf) 2006 Apr;64(4):444-9. Ahn CW et al.
P. 142: HGH increases amylin that protects from diabetes: 

Scientific World Journal. 2006 DEC 15;6:1642-55. Wookey PJ.; Eur J.Endocrinol. 2000 Nov;143(5):593-9. Jorgensen JO et al.
P. 142: HGH increases adiponectin that protects from diabetes: 

Horm Metab Res. 2005 Jan;37(1):49-52. Herrmann BL et al.
P. 142: HGH reduces overall body fat: 

Clin Endocrinol. (Oxf) 2003 Oct;59(4):467-75. McMillan CV et al

P. 144: By ages 50-60 most will lose 70% of DHEAS level enjoyed in 20s: 

Endo Reviews. 2003 Apr;24(2):152-182 Labrie F et al.; J Clin Endo Met. 1992;75(4):1002-4 Orentreich N et al.; J Clin Endocrinol Metab. 1984;59(3):551-5. Orentreich N et al.
P. 144: DHEA levels peak between ages 20-30/plummet between ages 50-60: 

Endo Reviews. 2003 Apr;24(2): 152-182 Labrie F et al.; J Clin Endo Met. 1992;75(4): 1002-4 Orentreich N. et al.
P. 144: DHEA levels decline less after age 60: 

J Clin Endo & Metab. 1997 ;82: 2396-2402 Lebrie F et al.
P. 144: Measurable decline in DHEA production after hysterectomy: 

Fertil Steril. 2006 Oct;86(4): 981-9 Hassa H et al.
P. 146: Promising reports of DHEA: 

Fertil Steril. 2003 Dec;80(6): 1495-501 Genazzani AD et al.; J Clin Endocrinol Metab. 1999;84(9)3260-7 Solerte SB et al.; Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.; Cell Mol Immunol. 2006 Feb;3(1): 41-5 Wang YD et al.; J Clinic Endo and Metab. 2002 May;87(5): 2046-52 Gudmundur J et al.
P. 146: Negative DHEA reports: 

N Engl J Med. 2006 Oct 19;355(16): 1647-59 Nair KS et al.; Semin Reprod Med. 2006 Apr;24(2): 97-105 Saltzman E et al.; Treat Endocrinol. 2005;4(2): 95-114 Cameron DR et al.; Trends Endocrinol Metab. 2002 Sep;13(7): 288-94 Allolio B et al.
P. 146: DHEAS—ready to use when needed: 

Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.
P. 147: Androgens play important role in women’s health: 

Gynecol Endocrinol. 2006 Mar;22(3): 118-30 Labrie F.
P. 147: Supplementing DHEA decreases breast cancer: 

Endo Reviews. 2003 Apr;24(2): 152-182 Labrie F et al.; World J Surgery. 2007 Apr 4; Published Online Hardin C et al.
P. 147: DHEA suppressed growth of human breast cancer cells in mice: 

Carcinogenesis 2003;105(3):321-325. Ciolino H et al.; Cancer J. 2006 Mar-Apr;12(2):160-5. Gayosso V et at.; Breast Cancer Res. 2005;7(6):R1132-40. Shilkaitis A et al.
P. 147: DHEA inhibits progression of breast cancer: 

Cáncer J. 2006 Mar-Apr;12(2): 160-5 Gayosso V et al.; Breast Cancer Res. 2005;7(6) R1132-40 Shilkaitis A et al.
P. 147: Aromatase inhibitors (regular breast cancer treatment) in the absence of androgens are not as efficient as could be: 

Endocrin-Related Cancer. 2006 Aug 1;13: 335-355 Labrie F.; Cancer Res. 2006 Aug 1;66(15): 7775-7782 Macedo LF et al.
P. 147: DHEA suppresses production of 4 Hydroxy esterone (that may increase breast cancer): 

CG. Mol Cell Biochem. 1999;198: 89-100. Ikegwuonu FI et al.; Carcinogenesis 2003;105(3):321-325 Ciolino H et al.
P. 148: Multiple studies show general anti-cancer effect of DHEA: 

Cancer Lett. 1997 Jun 3;116(1): 61-69 Wang TT et al.; Carcinogenesis 2003;105(3):321-325. Ciolino H et al.
P. 148: Animal studies indicate anti-cancerous effect of DHEA on pancreatic cancer: 

Surgery. 1997;121(4): 392-7 Melvin WS et al.
P. 148: Animal studies indicate anti-cancerous effect of DHEA on colon cancer: 

Carcinogenesis. 1984;5(1): 57-62 Nyce JW et al.; Cancer Res. 1992;52:1372-76. Schulz S et al.
P. 148: Animal studies indicate anti-cancerous effect of DHEA on prostate cancer: 

Cancer Res. 1999 Jul 1;59(13): 3084-9 Rao KV et al.
P. 148: DHEA benefits the cardiovascular system: 

J Cardiovasc Pharmacol. 2005 Sep;46(3): 325-32 Hutchison SJ et al.; Endocrinol Pol. 2005 Nov-Dec;56(6): 904-10 Rabijewski M et al.; Circulation. 1993;87: 261-9 Eich DM et al.
P. 148: Low DHEA associated with increase atherosclerosis: 

Euro J Endocrinol. 2007 Jun;156(6):687-93
P. 148: DHEA inhibits platelet aggregation: 

Ann NY Acad Sci. 1995;774: 281-90 Jesse RL et al.
P. 148: DHEA reverse aging process of left heart ventricle: 

Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1): R251-6 Alwardt CM et al.
P. 148: DHEA protects the cardio vascular system: 

J Nut Cancer Inst. 1998 may 20;90(10):772-80. Couillard S et al.
P. 148: DHEA is high in Polycistic Ovarian Syndrome patients as cardio protective reponse by their bodies: 

Eur J Endocrinol. 2006 Jun;154(6): 883-90 Dagre A et al.
P. 149: DHEA improves overall condition of diabetes: 

Ann NY Acad Sci. 1995;774: 291-3 Bates GW et al.
P. 149: DHEA improves insulin sensitivity: 

Euro J Endo. 2001 Oct;145(4): 457-61 Lasco A et al.
P. 149: DHEA increases pancreatic cells: 

FEBS Lett. 2006 Jan 9;580(1): 285-90 Medina MC et al.
P. 149: EA decreases insulin resistance in people with coronary disease: 

Endokrynol Pol. 2005 Nov-Dec;56(6): 904-10 Rabijewski M et al.
P. 149: DHEA protects diabetic patients from oxidative stress: 

Diabetes Care. 2007 Aug 17; Brignardello E et al.
P. 149: DHEA increases adiponectin: 

Endocrinology Reviews. 2005;26(3): 439-451 Kadowaki T et al.
P. 149: Supplementing DHEA up-regulates adiponectin levels: 

Eur J Endocrinol. 2006 Oct;155(4): 593-600 Hernandez-Morante JJ et al.
P. 149: DHEA increases NK activity: 

J Clin Endocrinol Metab. 1999;84(9)3260-7 Solerte SB et al.
P. 149 DHEA slows onset of autoimmune disease: 

Autoimmunity. 1997;26(3): 161-71 Norton SD et al.
P. 150 DHEA improves wound healing: :

J Invest Dermatol. 2005 Nov;125(5): 1053-62 Mills SJ et al.
P. 150: DHEA Enhances body’s response to viral disease: 

J Gen Virol. 2005 Sep;86(9): 2513-23 Chang CC et al.
P. 150: DHEA enhances body’s response to parasite and bacteria: 

Crit Care Med. 2001;29(2): 380-4 Berbeck R et al.
P. 150: DHEA reduces body’s inflammation response: 

J Interferon Cytokine Res. 2006 Jan;26(1): 34-9 Powell JM et al.
P. 150: DHEA decreases pro-inflammatory cytokines: 

Atherosclerosis. 2006 Mar 28; Gutierrez G et al.; J Clin Endo Metab. 2004 Jul;89(7): 3449-54 Iwasaki Y et al.
P. 150: DHEA decreases incidence of cold, flu, and allergies: 

Vaccine. 1995;13(15)L1445-8. Danenberg HD et al.; J Am Geriatr Soc. 1997 Jun;45(6):747-51. Degelau J et al.; J Microbiol Immunol Infect. 2002 Sep;35(3):199-202. Yu CK et al.; J Rheumatol. 2001 Jun:28(6):1259-65. Valtysdottir ST et al.
P. 150: DHEA reduces colitis: 

Endocrinology. 1997 Aug;138(8):3387-94 Luo S et al.
P. 150: DHEA reduces endometriosis: 

Atherosclerosis. 2006 Mar 28; Gutierrez G et al.
P. 150: DHEA reduces lupus: Curr Opin Invstig Drugs. 2001 Aug;2(8): 

1045-53 Dequet CR et al.; Autoimmunity. 2005 Nov;38(7): 531-40 Nordmark G et al.
P. 150: DHEA reduces psoriasis: 

Clin Exp Rheumatol. 1995 May-Jun;13(3): 345-8 De La Torre B et al.
P. 150: DHEA reduces rheumatoid arthritis: 

Arthritis Rheum. 2005 Jun;52(6): 1721-9 Weidler C et al.; J Rheumatol. 2000;59 Suppl 2: II/108-18 Straub RH et al.; J Rheumatol. 2002 Aug;29(8): 1803-5 Josipovic B et al.
P. 150: DHEA reduces osteoarthritis and joint pain: 

Rheumatol Int. 2006 Oct 11; Wu LD et al.
P. 150: DHEA functions as general anti-oxidant: 

Endocrinology. 1997 Aug;138(8): 3387-94 Luo S et al.; Cancer Res. 2001 Oct 15;61(21)7449-55. Green J et al.; Brain Res Mol Brain Res. 1999;66(1-2):35-41. Bastianetto S et al.
P. 150: DHEA decreases depression and improve felling of well-being: 

J Clin Endocrinol Metab. 2006 Oct ;91(10): 3773-9 Brooke AM et al.; Am J Psychiatry. 2006 Jan;163(1): 59-66 Rabkin JG et al.; J Clinic Endo and Metab. 2002 May;87(5): 2046-52 Gudmundur J et al.; Amer J Psychiatry. 1999 Apr;156(4): 646-9 Woldowitz OM et al.; Autoimmunity. 2005 Nov;38(7): 531-40 Nordmark G et al.
P. 150: DHEA treatment may resolve depression in children: 

Eur Neuropsychopharmacol. 2007 Aug 20; Malkesman O et al.
P. 150: DHEA shown to reduce anxiety: 

Pharmacol Biochem Behav. 1994 Mar;47(3): 437-41 Melchior CL et al.
P. 151: DHEA decreases cortisol: Acta Psychiatr Scand. 2006 Sep;114(3): 187-93 Yehuda R et al.; J Clin Endocrinol Metab. 1996 Nov;81(11): 3951-60 Guazzo EP et al.
P. 151: DHEA increases estrogen: Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.
P. 151: DHEA increases progesterone and allopregnenolone: 

Maturitas. 2003 Jul 25;45(3): 231-5 Nadjafi-Triebsch C et al.
P. 151: DHEA decrease pain: 

FASEB J. 2007 Aug 24; Kibaly C et al
P. 151: DHEA protects the hippocampus from injury and free-radicals: 

J Neurochem. 2002 Nov;83(3): 713-26 Steckelbroeck S et al.; Neuropharmacology. 2006 Oct;51(5): 958-66 Li Z et al.; Brain Res Mol Brain Res. 1999;66(1-2): 35-41 Bastianetto S et al.
P. 151: DHEA an effective treatment in vascular and neuronal-related disease: 

Amer J Physiol Endocrinology and Metabolism. 2002 Nov;283(5): E1067-75 Yorek MA et al.
P. 151: DHEA improves muscle mass and strength following resistance exercises: 

Am J Physiol Endocrinol Metab. 2006 Nov;291(5): E1003-8 Villareal DT et al.
P. 151: DHEA improves bone mass: 

Cell Mol Immunol. 2006 Feb;3(1):41-5. Wang YD et al.; Clin Endocrinol (OXF). 2000 Nov;53(5): 561-8 Villareal DT et al.
P. 152: DHEA improves bone density in spine: 

J Clin Endocrinol Metab. 2006 Aug;91(8): 2986-93 Jankowski CM et al.
P. 152: DHEA decreases bone loss: 

Cell Mol Immunol. 2006 Feb;3(1): 41-5 Wang YD et al.
P. 152: DHEA necessary for high-altitude acclimation: 

High Alt Med Biol. 2006 Fall;7(3): 228-36 Lee WC et al.
P. 152: DHEA affects sexual arousal and response: 

Fertil & Steril. 2002 Apr;77(4): S19-S25 Spark RF.
P. 152: DHEA megadose in double-blind studies showed increased sex drive and better orgasmic response: 

J Womens Health Gend Based Med. 2002 Mar;11(2): 155-62 Hackbert L et al.
P. 153: DHEA increases HGH: 

Clin Endocrinol. (OXF). 2006 Nov;65(5): 673-80 Brooke AM et al.; Fertil and Steril. 2001 Aug;76(2)241-248 Genazzani AL et al.
P. 153: DHEA increases allopregnenolone and endorphins: 

Fertil Steril. 2003 Dec;80(6): 1495-501 Genazzani AD et al.
P. 153: DHEA converts into estrogen: 

Endocr Rev. 2003 Apr;24(2): 152-82 Labrie F et al.
P. 153: DHEA increases progesterone levels: 

Maturitas. 2003 Jul 25;45(3): 231-5 Nadjafi-Triebsch C et al.
P. 153: DHEA reduces cortisol: 

Encephale. 2002 Mar-Apr;28(2): 139-46 Boudarene M et al.; Acta Psychiatr Scand. 2006 Sep;114(3): 187-93 Yehuda R et al.; J Clin Endocrinol Metab. 1996 Nov;81(11): 3951-60 Guazzo EP et al.
P. 153: DHEA decreases high levels of cortisol: 

Encephale. 2002 Mar-Apr;28(2): 139-46 Boudarene M et al.
P. 154: Women with adrenal deficiency and low cortisol tolerate higher levels of DHEA: 

Treat Endocrinol. 2005;4(2): 95-114 Cameron DR et al.
P. 154: DHEA can correct Graves’ Disease and Hashimoto’s Thyroiditis: Eur J Endocrinol. 2005 May;152(5): 

703-12 Solerte SB et al.
P. 154: DHEA decreases hot flashes: P.

Endo Reviews. 2003 Apr;24(2): 152-182 Labrie F et al.
P. 154: DHEA reduces middle ear infections: 

J Pharmacol Sci. 2005 Oct;99(2): 191-4 Tabuchi K et al.
P. 154: DHEA improves fertility treatment in previously unresponsive women: 

Human Reprod. 2006 Nov;21(11)2845-9 Barad D et al.
P. 155: DHEA levels rise with the implementation of Natural Superwoman eating: 

Exp Gerontol. 2003 Jan-Feb;38(1-2): 35-46 Mattison JA et al.
P. 155: Study indicating that people with lower levels of DHEA were more likely to die during course of three year study: 

Ann Epidemiol. 2006 Jul;16(7): 510-5 Glei DA et al.
P. 157: Why studies that include women with Policystic Ovarian Syndrome are misleading?: 

Obstet Gnecol Surv. 2006 Nov;61(11): 723-32 Himelein MJ et al.; ARQ Bras Endocrinol Metab. 2005 Oct;49(5): 805-10 Spritzer PM et al.
P. 157: In women with Polycystic Ovarian Syndrome high level of DHEA are protective: 

Eur J Endocrinol. 2006 Jun;154(6): 883-90 Dagre A et al.
P. 157: Study reporting 17 women given 50 mg. DHEA with an absence of side effects, it makes no sense that they had no side effects: 

J Clin Endocrinol Metab. 1994 Jun;78(6): 1360-7 Morales AJ et al.
P. 158: Majority of studies on liver cancer treatment with DHEA show reduced proliferation: 

Int J Oncol. 2004 Oct;25(4): 1021-30 Mayer D et al.
158: Extremely high dose given for very long time to achieve negative effect: 

Cancer Lett. 1997 Dec 23;121(2): 125-31 Metzger C et al.
P. 160: Sublingual DHEA administration: 

Climacteric. 2003 Jun;6(2): 104-11 Wren BG et al.
P. 160: Benefits of micronized form of DHEA: 

Am J Obstet Gynecol. 1996 Feb;174(2): 649-53 Casson PR et al.
P. 162: Opposite-than-expected response is usually due to low Norepinephrine levels: 

Neuroscie Lett. 1996 Feb 9;204(3):181-4 Liu PS et al.
P. 163: Ginseng enhances DHEA effectiveness: 

CMAJ. 2006 Apr 11;174(8): 1134 Howard JM.

P. 165: High doses of Pregnenolone prescribed as miracle drug for Rheumatoid Arthritis in 1950s: 

J Lancet1950 Jul;70(7):264-5 Cohen A et al.
P. 165: Pregnenolone historically regarded as “mother of all hormones”: 

J Steroid Biochem Mol Bioc. 1991;40(1-3):71-81 Akwa Y et al.
P. 166: Pregnenolone gives more alert feeling by suppressing GABA: 

Acta Physiol (OXF). 2006 Nov;188(3-4):153-62 Wang MD et al.
P. 166: Pregnenolone protects from negative effects of increased glutamate by increasing dopamine: 

Pharmacol Biochem Behav. 2004 Aug;78(4):781-6 Maciejak P et al.
P. 166: Pregnenolone protects brain cells from Amyloid Beta Protein that is associated with alzheimer: 

Neurochem Res. 2001 Jan;26(1):15-21 Gursog et al.
P. 166: Less frequently the beta form of pregnenolone increases GABA: 

J Clin Endocrinol Metab. 2006 Aug;91(8):3092-9 Havlikova H et al.
P. 166: Pregnenolone increases capacity for cognitive function: 

Pharmacol Biochem Behav. 2004 Aug;78(4):781-6 Maciejak P et al.; Neuroscience. 2005;133(1):147-57 Shirayama Y et al.
P. 166: Pregnenolone improves new brain cell generation: Prog Neurobiol. 2003 Sep;71(1):43-8 Mayo W et al.
P. 166: Pregnenolone supports over-all memory by increasing acetylcholine: 

Brain Res. 2000 Jan 3;852(1):173-9 Darnaudery M et al.; Prog Neurobiol. 2003 Sep;71(1):43-8 Mayo W et al.
P. 166: Pregnenolone specifically increases spatial memory: 

J Neuroscience. 2006 Oct 25;26(43):11034-40 Yau JL et al.
P. 166: Pregnenolone increases memory in the aged: 

Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12 Vallee M et al.
P. 166: Prozac or Fluoxetine increase level of pregnenolone in brain: 

Pharmacol Biochem Behav. 2006 Aug;84(4):609-17 Marx CE et al.
P. 168: Drinking alcohol increases pregnenolone in brain: 

Psychopharmacology. 2006 Jun;186(3):451-61 Pierucci-Lagha A et al.
P. 168: Our body increases pregnenolone when sedative medication is taken: 

Psychneuroendocrinology. 2004 May;29(4):486-500 Meieran Se et al.
P. 170: People with social-phobias have naturally low levels of pregnenolone: 

Psychol Med. 2002 Jul;32((5):929-33 Heydari B et al.
P. 170: Pregnenolone is found in concentrated levels in the eye: 

Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12 Vallee M et al.
P. 171: 500mg daily of pregnenolone were prescribed in 1950s with no side effect: 

J Lancet. 1950 Jul;70(7):264-5 Cohen A et al.
P. 171: Studies indicate presence of pregnenolone decreases cholesterol levels as a complete HRT program: 

Med Hypoteses. 2002 Dec;59(6):751-6 Ozugan SA et al.; Gastroenterology. 1984 Aug;87(2):284-92. Turley SD et al.
P. 171: Pregnenolone plays important role in embryonic process: 

Nature. 2006 Jan;439(7075):480-3 Hsu HJ et al.

P. 178: Testosterone level in the cell and tissue not blood tell us how much testosterone you have: 

Endocr Rev. 2003 Apr;24(2):152-82 Labrie F et al.; Endocrine Reviews. 2005 May;26(3):322-330. Simpson EL et al.
P. 178: Testosterone in a women’s body is attached to sex hormone binding globulin: 

Zentralbl Gynakol. 1995;117(10):504-7. Schindler AE.
P. 179: Women’s testosterone expression peaks in early 20s and decreases nearly 50% by mid-forties: 

Sex Health. 2006 May;3(2):73-8. Burger HG et al.
P. 179: 2007 report warned about “substantial, yet-unrecognized” recent decline in men testosterone blood level: 

J Clin Endo & Metab. Jan;92(1):196-202. Thomas G et al.
P. 181: Animal research shows specific areas of brain directly responding to testosterone: 

Front Neuroendocrinol. 1996;17(1):51-125. Panzica GC et al.
P. 181: Testosterone has been shown to benefit sexuality of women who haven’t undergone hysterectomy or removal of ovaries: 

Menopause. 2006 Sep-Oct;13(5):770-9 Shifren JL et al.
P. 181: Women with hysterectomy on estrogen benefit significantly with testosterone treatment:
P. 182: Testosterone significantly reduced women’s fear response: 

Biol Psychiatry. 2006 May 1;59(9):872-4 Hermans EJ et al.
P. 183: Testosterone supplementation has positive affect on depression: 

Climacteric. 2004 Dec;7(4):338-46 Studd J et al.
P. 183: Estrogen improves depression and sexual response: 

J Obstet Gynaecol Res. 2005 Apr;31(2):107-14 Nagata H et al.
P. 184: Addition of testosterone to men who take SSRI(Prozac) improved depression and sexual functions: 

J Affect Disord. 1998 Mar;48(2-3):157-61 Seidman SN et al.; J Clin Psychiatry. 2005 Nov;66(11):1409-14 Nelson JC et al.
P. 184: Testosterone combined with estrogen and Melatonin alleviates cluster headaches: 

Headache. 2006 Jun;46(6):925-33 Stillman MJ.
P. 184: Testosterone known as a bone-builder: 

Gynecol Endocrinol. 2005 Mar;20(3):155-60 Floter A et al.; Clin Endocrinol (Oxf). 2004 Nov;61(5):560-6. Turner A et al.; Maturitas. 2004 Jul 15;48(3):235-42 Tok EC et al.; Br J Obstet Gynaecol. 1992 Sep;99(9):757-60 Savvas M et al.; J Clin Endocrinol Metab. 1996 Jan;81(1):37-43 Raisz LG et al.
P. 184: Testosterone neuroprotective in treatment of MS in men: 

Arch Neurol. 2007 May;64(5):683-8 Sicotte NL et al
P. 185: Women undergoing IVF enjoy improved results when testosterone is added: 

Hum Reprod. 2006 Jul;21(7):1884-93 Balasch J et al
P. 185: Testosterone supports follicle function: 

Hum Reprod. 2006 May;21(5):1204-11 Massin N. et al
P. 185: Decreased testosterone levels associated with increase cardiovascular disease in menopause: 

Coron Artery Dis. 2007 feb;18(1):9-13 Montalcini T et al.
P. 185: Decreased testosterone in menopause increases thickness of carotid artery wall: 

J Clin Endocrinol Metab. 1999 Jun;84(6):2008-12 Bernini GP et al.
P. 185: Decreased testosterone associated with increase atherosclerosis: 

Eur J Endocrinol 2007 Jun;156(6):689-93. Debing E et al.
P. 185: Mice treated with testosterone show improvement in coronary artery function: 

Fertil Steril. 2006 Oct 31; Cooper BC et al
P. 186: Female-to-male transsexuals do not experience change in mortality: 

Metabolism. 1989 Sep;38(9):869-73 Asscheman H et al..
P. 186: Testosterone treatment helpful in preventing and treating diabetes: 

Int J Impot Res. 2006 Jul 20; Svartberg J.
P. 186: Women with polycystic ovaries and testosterone: 

Fertil Steril, 2006 Mar;85(3):679-88
P. 186: In female-to-male transsexuals large doses of testosterone have no affect on insulin sensitivity: 

Clin Endocrinol (Oxf). 2003 May;58(5):562-71 Elbers JM et al.
P. 186: Female HIV patients treated with high dose testosterone evidence no change in insulin sensitivity: 

Fertil Steril. 2006 Jun;85(6):1794-802. Herbst KL et al.
P. 186: Testosterone protects against breast cancer: 

Endocr Rev. 2003 Apr;24(2):152-82. Labrie F et al.; Cancer Res. 2006 Aug 1;66(15):7775-82. Macedo LF et al.; Menopause. 2007 Mar-Apr;14(2):183-90. Hofling M et al.
P. 186: Testosterone Protects breast cancer by decreasing breast tissue proliferation: 

Menopause. 2007 Mar-Apri;14(2):183-90 Hoflin M et al.
P. 187: Women to men transexuals have breasts like old postmenopausal women: 

J Histochem Cytochem. 2006 Aug;54(8):905-10. Stagter MH et al.
P. 187: Historically testosterone was the treatment of choice for breast cancer:
Eur J Surg Oncol. 1987 Apr;13(2):113-7. Karydas I et al.
P. 188: Oral contraceptives decrease close to 80% of the available testosterone: 

Contraception. 1999 Nov;60(5):255-62. Thorneycroft IH et al.; Acta Derm Venereol. 1984;64(6):517-23. Palatsi R et al.
P. 189: Mortality rates nearly 50% higher in women who remove their ovaries before age 45: 

Lancet Oncol. 2006 Oct;7(10):821-8. Rocca WA et al.
P. 189: Women lose 70% of testosterone within 72 hours after removal of their ovaries: 

Maturitas. 2002 Apr 15;41. Rohr UD.
P. 190: Premarin known to increase level of sex-binding globulin: 

Zentralbl Gynakol. 1995;117(10):504-7. Schindler AE.
P. 190: Women lose sexual drive and function from anti depressive medication and SSRI: 

NJ Clin Psychiatry. 2001;62 Suppl 3:22-34. Ferguson JM.; Psychother Psychosom. 2006;75(3):187-8. Csoka Ab et al.
P. 190-191: Metyl-testosterone is toxic to liver: 

N Engl J Med. 1952 Jan 31;246(5):176-9. Brick IB et al.; Ann Intern Med. 1954 Jan;40(1):146-52. Almaden PJ et al.; Bull New Engl Med Cent. 1952 Aug;14(3):87-9. Bonner CD et al.; Am J Med. 1950 Mar;8(3):325-31. Werner SC et al.; Toxicology. 1977 Jun;7(3):357-65. Heywood R. et al.; Bull New Engl Med Cent. 1952 Aug;14(3):87-9. Bonner CD et al.; Gastroenterology. 1956 Oct;31(4):384-90. Kaplan AA.
P. 191: There is no established normal blood level for testosterone in women: 

Curr Opin Urol. 2002 Nov;12(6):503-7. Anastasiadis AG et al.
P. 191: Many tests yield falsely high results: 

NAnn Clin Biochem. 2007 Jan;44(Pt 1):5-15. Kane J et al.
P. 191: Because of sloppy testing medical authorities have concluded that it is not possible to make educated assessment about existence of androgen deficiency: 

J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. Wierman ME et al.
P. 191: Testosterone expression is determined by levels in cells and tissues (targets): 

Endocr Rev. 2003 Apr;24(2):152-82. Labrie F et al.
P. 191: Measure of sexual response is not based on blood level: 

J Sex Med. 2005 May;2(3):291-300. Basson R et al.
P. 191: FDA and various medical associations contend women cannot benefit from testosterone supplementation: 

J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. Wierman ME et al.
P. 191: Bioidentical testosterone in pill form decreases women’s level of HDL and fails to yield as good results as other forms: 

Growth Horm IGF Res. 2006 Jul;16 Suppl A:S109-17. Braunstein GD.; J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. Wierman ME et al.
P. 191: In US women can get Metyl-testosterone which has found to be toxic to liver: 

N Engl J Med. 1952 Jan 31;246(5):176-9. Brick IB et al.; Ann Intern Med. 1954 Jan;40(1):146-52. Almaden PJ et al.; Bull New Engl Med Cent. 1952 Aug;14(3):87-9. Bonner CD et al.; Toxicology. 1977 Jun;7(3):357-65. Heywood R et al.; Am J Med. 1950 Mar;8(3):325-31. Werner SC et al.; Gastroenterology. 1956 Oct;31(4):384-90. Kaplan AA.
P. 192: Sublingual testosterone reaches effect in 15 minutes and restores levels within two hours: 

Arch Gen Psychiatry. 2000 Feb;57(2):149-53. Tuiten A et al.
P. 192: Vaginally applied testosterone cream or gel peaks at 5.5 hours and lasts more than 12: 

J Sex Med. 2006 May;3(3):541-9. Apperloo M et al.
P. 196: Caffeine may counteract loss of head hair and chin hair growth from testosterone: 

J Sex Med. 2006 May;3(3):541-9. Apperloo M et al.
P. 196: Caution against use of Propecia: 

Nat Med. 2004 Jul;10(7):704-11. Griffin LD et al.; Semin Cell Dev Biol. 2004 Aug;1594):445-54. Ikonen E et al.

P. 212: Stress produces cardiovascular deterioration: 

PNAS. 1997;94:P9960 et al.; J Nutr Health Aging. 2004;8(3):163-74. Bourre JM et al.; J Med Genet. 2006 Oct;43(10):e52. Lehmann DJ et al.; FEBS Lett. 2006 Dec 11;580(28-29):6730-40. Lu J et al.
P. 212: Oxidative Stress markers decrease immunity: 

Neurology. 2006 Oct 24;67(8):1370-6. Morris MC et al.; J Nutr Health Aging. 2004;8(3):163-74. Bourre JM.
P. 212: Chronic activation of stress response leads to wear and tear and predisposes to disease: 

Proc Biol Sci. 2006 Apr 7;273(1588):881-5. Hadany L et al.
P. 212: Stress elevates blood pressure: 

J Hum Hypertens. 2003 Dec;17(12):829-40. Schneider GM et al.; Croat Med J. 2006 Jun;47(3):416-23. Santic Z et al.
P. 212: Stress increases memory loss: 

FASEB J. 2006 Apr;20(6):729-31. Jeong YH.; J Neurosci. 2006 Mar 22;26(12):3309-18. Son GH et al.; Psychol Aging. 2006 Jun;21(2):424-9. Neupert SD.; Biol Psychiatry. 2006 Oct 1;60(7):722-9. Morgan CA et al.
P. 212: Stress increases Oxidative Stress: 

Rinsho Byori. 2005 Feb;53(2):155-9. Shioji I.; Biochem Biophys Res Commun. 2006 Oct 20;349(2):775-80. Miyashita T et al.
P. 212: Stress increases risk of breast cancer: 

Am J Epidemiol. 2003 Mar 1;157(5):415-23. Lillberg K et al.
P. 212: Stress increases back pain: 

J Occup Environ Med. 2006 Jun;48(6):607-14. Feuerstein M et al.
P. 212: Stress increases headache: 

Headache. 2006 Oct;46(9):1377-86. Nash JM et al.
P. 212: Stress increases hair loss: 

Dermatology. 2006;213(1):44-5. Atefi N et al.
P. 212: Holding breath shown to reduce oxidative stress and acidity in blood: 

Respir Physiol Neurobiol. 2002 Oct 23;133(1-2):121-30. Joulia F et al.
P. 220: Women with chronic fatigue syndrome show adrenal glands decreases 50%: 

Cell Mol Biol Lett. 2005;10(4):669-76. Haider S et al.
P. 223: Yoga and meditation improve endo thelial function: 

Clin Cardiol. 2006 Sep;29(9):393-8. Sivasankaran S.
P. 225: DHEA counterbalances negative affects of high cortisol: 

Treat Endocrinol. 2005;4(2):95-114. Cameron DR.; Encephale. 2002 Mar-Apr;28(2):139-46. Boudarene M et al.
P. 225: DHEA increases progesterone, alloprenenolone, and endorphin production: 

Fertil Steril. 2003 Dec;80(6):1495-501. Genazzani AD et al.
P. 226: Melatonin lowers levels of nighttime cortisol and avoid further adrenal deterioration: 

Med Sci Monit. 2005 Jun;11(6):CR284-288. Mazzoccoli G et al.; J Physiol. 2004 Feb 1;554(Pt 3):841-56. Torres-Farfan C et al et al.
P. 226: Women in Adrenal Over-Production group can benefit by correcting HGH deficiency: 

Neuroscience. 2004;123(2):429-40. Molteni R et al.
P. 228: Hydrocortisol can bridge body’s need for cortisol while adrenal gland recovers: 

Journal Clinic Endo & Metab. 2001 Aug;86(8):3545-3554. Cleare AJ et al.; Psychophysiology. 2006 Nov;43(6):653-6. Tops M et al.

P. 246: SAMe can be efficient anti-depressant: 

Acta Neurol (Napoli). 1978 May-Jun;33(3):243-55. Miccoli L et al.; Am J Clin Nutr. 2002;76(5):1158S-1161S. Mischoulon D et al.

P. 273: Definition of insomnia: 

Am J Med. 2006 Jun;119(6):463-9. Kamel NS et al.
P. 273: 10% of Americans suffer from insomnia; 25-35% suffer occasionally: 

Am J Manag Care. 2006 May;12(8 Suppl):S214-20. Doghramji K.
P. 274: Insomnia afflicts more women; more so as they age: 

Am J Med. 2006 Jun;119(6):463-9. Kamel NS et al.
P. 275: Body does not allow sleep when under stress: 

Psychosom Med. 2003 Mar-Apr;65(2):259-67. Morin CM et al.
P. 276: Abnormal sleep patterns correlate to lower life expectancy: 

Am J Manag Care. 2006 May;12(8 Suppl):S214-20. Doghramji K.
P. 276: One third to half of insomniacs suffer from mood disorders and substance abuse: 

Sleep Med rev. 2000 Jun;4(3):253-262. Lustberg L et al.; Sleep Med Rev. 1997 Nov;1(1):45-56. Benca RM et al.
P. 276 Sleep disorders increase incidents of cardiovascular disease and related death: 

J Psychosom Res. 1999 Oct;47(4):313-33. Schwartz S et al.; Ann Epidemiol. 1998 Aug;8(6):384-92. Schwartz SW et al.
P. 276: Sleep deficiency may bring on/enhance depression: 

Sleep Med Rev. 2000 Jun;4(3):253-262. Lustberg L et al.
P. 277: Stress and anxiety can enhance insomnia: 

Psychosom Med. 2003 Mar-Apr;65(2):259-67. Morin CM et al.
P. 277: Insomnia enhance headaches: 

Sleep Med Rev. 2002 Dec;6(6):471-9. Jennum P.
P. 281: Estrogen and progesterone should be first line of defense against insomnia: 

J Br Menopause Soc. 2004 Dec;10(4):145-50. Polo-Kantola P et al.
P. 282: Melatonin found throughout the natural world: 

FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.
P. 282: Melatonin hormone produced in retina, gastrointestinal tract, skin, bone marrow and lymphocytes: 

FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.
P. 282: Melatonin is free-radical scavenger: 

Comb Chem High Throughput Screen. 2006 Jul;9(6):409-19. Suzen S.; FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.; J Endocrinol Invest. 2006 Mar;29(3):281-7. Aydogan S et al.; Behav Brain Funct. 2006 May 4;2(1):15. Srinivasan V et al.; Biosci Rep. 2007 Sep 7 7; Maharaj DS et al.; J endocrinol. 2007 Sep;194(3):637-43. Rodriguez MI et al.
P. 282: Melatonin deficiency increase weight gain and depression: 

J Soc Biol. 2007;
201(1):105-13. Guardiola-Lemaitre PB.
P. 282: Melatonin alleviates depression improving thyroid function: 

Ann N Y Acad Sci. 2005 Dec;1057:393-402. Bellipanni G et al.; J Psychiatry Neurosci. 2000
P. 283: Melatonin decreases anxiety: 

Prog Neuropsychopharmacol Biol Psychiatry.
2000 Jan;24(1):117-29. Naranjo-Rodriguez EB et al.
P. 283: Melatonin promotes blood platelets health: 

Neuro Endocrinol Lett. 2006 Aug 5;27(4). Bella LD.
P. 283: Melatonin prevent post surgical adhesions: 

Yonsei Med J. 2007 Aug 31;48(4):659-64. Hatipoglu A et al.
P. 283: In ulcerative colitis, melatonin repairs damage to the mucosal of the GI system: 

Dig Dis Sci. 2006 Sep;51(9):1538-45. Necefli A et al.
P. 283: Melatonin repair duodenal ulcer: 

Klin Med (Mosk). 2006;84(1):5-11. Malinovskaia N K et al.
P. 283: Melatonin repair acute esophageal ulcer; J Physiol Pharmacol. 2007 Jun;58(2):361-77. Konturek SJ et al.
P. 283: Melatonin maybe the future treatment for all acid reflux problems: 

Pol Merkur Lekarski. 2007 May;22(131):332-5. Walecka-Kapica E et al.
P. 283: Melatonin helps heal tinnitus: 

Otolaryngol Head Neck Surg. 2006 Feb;134(2):210-3. Megwalu UC et al.
P. 283: Melatonin may protect from ALS: 

J Pineal Res. 2006 Nov;41(4):313-23. Weishaupt JH et al.
P. 283: Melatonin may protect from Alzheimer’s; Behav Brain Funct. 2006 May4;291):

15. Srinivasan V et al.
P. 283: Melatonin helps alleviate hypertension: 

Am J Hypertens. 2005 Dec;18(12 Pt 1):1614-8. Cagnacci A et al.
P. 283: Melatonin decrease endometriosis: 

Fertil Steril. 2007 Jun 18; Guney M et al.
P. 283: Melatonin boosts and improves immune system: 

Med Sci Monit. 2006 Aug 25;12(9): BR307-312. Ergun Y et al.; Mol Cell Biochem. 2006 Aug 24. Cubero J et al.; Expert Opin Invest 16 Drugs. 2001 Mar;10(3):467-76. Maestroni GJ et al.
P. 284: Melatonin reduces cholesterol levels: 

Nuero Endocrinol Lett. 2002 Apr;23(1):79-83. Sewerynek E.
P. 284: Melatonin decreases brain vascular damage: 

Neurosci Lett. 2002 Feb 1;318(3):141-4.
P. 284: Meltatonin is used for treating cluster headaches: 

Curr Pain Headache Rep. 2006 Apr:10(2):147-52. Sillman M.
P. 284: Women with lower levels of melatonin are more likely to suffer migraines: 

CNS Drugs. 2006;20(5):343-50. Vogler B et al.
P. 284: Melatonin treatmet for migraines: 

CNS Drugs. 2006;20(5):343-50. Vogler B et al.
P. 284: Melatonin increases glutathione formation: 

Neuro Endocrinol Lett. 2006 Jun 2;27(3). Swiderska-Kolacz G et al.
P. 284: Melatonin protects kidney from damage caused by kidney infection: 

Urology. 2006 Jun;67(6):1315-9. Imamoglu M et al.
P. 284: Melatonin improves and resolves dry eye syndrome: 

Eur J Pharmacol. 2006 Dec 15;552(1-3):159-61. Hoyle CH et al.
P. 284: Melatonin helps combat damaging effect of high blood sugar: 

Acta Histochem. 2006;108(2):85-93. Guven A et al.
P. 284: Melatonin protects against osteoporosis: 

J Pineal Res. 2003 Mar;34(2)143-51. Ladizesky MG et al.
P. 285: Melatonin inhibits proliferation and metastasis of cancerous tumors: 

Cancer Detect Prev. 2006;30(2):118-28. Cos S et al.
P. 285: Melatonin may protect from pancreatic cancer: 

J Pineal Res. 2007 Oct;43(3):270-5. Ruiz –Rabelo JF et al.
P. 285: Melatonin increases efficacy and decreases side effect of chemotherapy: 

Cancer Res. 2006 Oct 15;66(20):9789-93. Jung B et al.
P. 285: Melatonin acts as a natural aromatase inhibitor: 

J Pineal Res. 2005 Mar;38(2):136-42. Cos et al.
P. 285: Melatonin and Vitamin D-3 increases the realease of TGF Beta 1, reduce growth of breast cancer: 

J Surg Res. 2003 Apr;110(2):332-7. Bizzarri M et al.
P. 285: Melatonin is able to reverse the decline and rise of hormonal function associated with aging: 

Ann N Y Acad Sci. 2005 Dec;1057:393-402. Bellipanni G et al.
P. 286: In post-menopausal women, melatonin suppresses rise of LH: 

BMC Womens Health. 2006 May 16;6:8. Kripke DF et al.
P. 286: Increase of FSH and LH is first sign of decreased ovarian function and an aging hormonal system: 

BMC Womens Health. 2006 May 16;6:8. Kripke DF et al.
P. 286: Six-month treatment with melatonin changes gonadotropin: 

Ann N Y Acad Sci. 2005 Dec;1057:393-402. Bellipanni G et al.
P. 286: Melatonin in high doses has contraceptive effects: 

Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):3-9. Silman RE et al.
P. 286: Melatonin improves brain’s response to inflammation: 

J Neuroimmunol. 2006 Oct 27. Perreau VM et al.
P. 286: Melatonin helps with jet-lag: 

Uqeskr Laeger. 2001 Jan 8;163(2):149-55. Christiansen AL et al.; Chochrane Database Syst Rev. 2002;(2):CD00152. Herxheimer A et al.; BMJ. 1989 Mar 18;298(6675):705-7. Petrie K et al.; J Mol Microbiol Biotechnol. 2002 Sep;495):463-6. Parry BL.
P. 286: Melatonin significant sleep aid: 

FEBS J. 2006 Jul;273(13):2813-38. Pandi-Perumal SR et al.; J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):233-41. Van der Heijden KB et al.; Z Gerontol Geriatr. 2001 Dec;34(6):491-7. Olde Rikkert MG et al.; Curr Med Res Opin. 2007 Sep 14; Wade AG et al.
P. 287: Using Melatonin with Arginine to decrease oxidative damage of NO: 

J Endocrinol Invest. 2006 Mar;29(3):281-7. Aydogan S et al
P. 287: Melatonin help fertility: 

J Pineal res. 2007 Oct;43(3):283-8. Rodriguez-Osorio N et al.

P. 295: Insulin resistance increase levels of GSK-3, that is destructive to the brain ultimately causing apastosis: 

Exp Gerontol. 2007 Jan-Feb;42(1-2):10-21. Cole GM et al.
P. 295: Women with Alzheimer’s have increased levels of GSK-3: 

Eur J Neurosci. 2007 Jan;2591):81-86. Hooper C et al.
P. 295: Memory and brain function of women with diabetes more likely to have memory and brain function problems: 

J Diabetes Complications. 2006 Jul-Aug;20(4):238-45. Debling D et al.
P. 296: Adults with Type 2 Diabetes evidence better cognitive performance following just one low glycemic index, low carbohydrate meal: 

Diabetologia. 2006 May;49(5):855-62. Papanikolaou Y et al.
P. 296: Diet that promotes insulin resistance proven to promote alzheimer: 

FASEB J. 2004 May;18(7):902-4. Ho L et al.; Exp Gerontol. 2007 Jan-Feb;42(1-2):10-21. Cole GM et al.
P. 296: Fruit has higher glycemic index and does not help the brain: 

Neurology. 2006 Oct 24;67(8):1370-6. Morris MC et al.
P. 297: DHEA increases AKT-PI3K that protect the brain: 

Brain Res Mol Brain Res. 2002 Jan 31;98(1-2):58-66. Zhang L et al.
P. 297: Melatonin increases AKT-PI3K: J Pineal Res. 2006 Jan;40(1):79-85. Lee SH et al.
P. 297: Memantine/Galatamine promotes memory and decreases GSK-3 that is destructive to the brain: 

Neurobiol Aging. 2006 Mar;27(3):413-22. De Sarno P et al.
P. 298: The scientific community did not believe that our diet can influence brain function: 

J Nutr Health Aging. 2004;8(3):163-74. Bourre JM.
P. 298: Omega-3 deficient diets can cause structural abnormalities and a decline in cognitive function: 

J Nutr Health Aging. 2004;8(3):163-74. Bourre JM.; J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99. Bourre JM.
P. 298: High fat and refined sugar reduces BDNF that is the key to proper brain function: 

Neuroscience. 2002;112(4):803-14. Molteni R et al.
P. 298: Consuming saturated and trans-fats lower cognitive function: 

Neurology. 2004 May 11;62(9):1573-9. Morris MC et al.
P. 298 Diets high in saturated fasts have been shown to aggravate outcome of tramatic brain injuries: 

Neuroscience. 2003;119(2):365-75. Wu A et al.
P. 298: Studies indicate that it doesn’t take long for unfavorable fats to have negative effect on cognitive function: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99. Bourre JM.
P. 299: Positive effects of vitamin and minerals on brain activity: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.; J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99. Bourre JM.
P. 299: Vitamin B-1 (Thiamine) improves cognitive function: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 299: Vit C is found in high concentration in brain nerve ending: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.; Am J Geriatr Psychiatry. 2006 Dec;14912):1032-40. Wilkins CH et al.
P. 299: Vitamin D plays an important role in nerve tissue chemistry: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 300: Vitamin E protects the brain membrane: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.; Arch Neurol. 2002 Jul;59(7):1125-32. Morris MC et al.
P. 300: Vitamin K plays an important role in nerve tissue chemistry: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 300: Lipoic Acid provides core brain function protection: 

Pharmacol Ther. 2007 Jan;113(1):154-64. Holmquist L et al.; Neurobiol Aging. 2007 Feb;28(2):213-25. Quinn JF et al
P. 301: Iron is necessary for oxygenation and energy production: 

J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85. Bourre JM.
P. 301: Iron levels that are too high increase free radicals and risk of Alzheimer’s disease: 

J Med Genet. 2006 Oct;43(10):e52. Lehmann DJ et al.
P. 301: Magnesium is essential for synaptic transmission, brain enzymatic and brain cell activity: 

Magnes Res. 2006 Sep;19(3):199-215. Billard JM.; Clin Calcium. 2004 Aug;14(8):60-4. Enomoto T et al.
P. 301: Magnesium given before open heart surgery decreases cognitive decline: 

J Thorac Cardiovasc Surg. 2006 Apr;131(4):853-61. Bhudia SK et al.
P. 301: Zinc taking patients experience improvement in spatial working and visual memory: 

Br J Nutr. 2006 Oct;96(4):752-60. Maylor EA et al.
P. 301: Excess heavy metals have no place in the body and are destructive to the memory: 

Cell Molk Biol Lett. 2005;10(4):669-76. Haider S et al.; Occup Environ Med. 2005 Mar;62(3):181-7. Bleecker ML et al.; J Occup Environ Med. 2005 Sep;47(9):902-8. Chen SS et al.; Neurotoxicology. 2006 Mar;27(2):291-5. Tsai YT et al.
P. 301: Taurine protects from lead toxicity while improving neuron-transmitter production: 

Neuroscience. 2005;134(1):215-24. Zhu DM et al.
P. 304: Phosphatidylserine found in inner leaflet of brain cell membrane: 

Sports Med. 2006;36(8):657-69. Kingsley M.
P. 304: Phosphatidylserine plays role in maintaining proper function of brain cell membranes: 

Isr J Psychiatry Relat Sci. 2000;37(4):302-7. Schreiber S et al.
P. 304: Phosphatidylserine increases acetyl cholin: 

J Nutr. 2001 Nov;131(11):2951-6. Suzuki S et al.; Jpn J Pharmaacol. 1997 Dec;75(4):447-50. Furushiro M et al.
P. 304: Phosphatidylserine increases serotonin: 

Jpn J Pharmaacol. 1997 Dec;75(4):447-50. Furushiro M et al.
P. 304: Phosphatidylserine improves memory within six weeks: 

Isr J Psychiatry Relat Sci. 2000;37(4):302-7. Schreiber S et al.; Neurology. 1991 May;41(5):644-9. Crook TH et al.
P. 304: Phosphatidylserine derived from soy lecithin may be superior to supplement with: 

Nutrition. 1999 Oct;15(10):778-83. Blokland A et al.
P. 304: Phosphatidylserine may decrease cortisol levels: 

Sports Med. 2006;36(8):657-69. Kingsley M.
P. 304: Acetyl-L-Carnitine can decrease free radical oxidative stress and improve spatial memory and overall cognitive function: 

J Neurosci Res. 2006 Aug 1;84(2):398-408. Abdul HM et al.; J Gerontol A Biol Sci Med Sci. 1995 Jul;50(4):B232-36. Caprioli A et al.; Drugs Exp Clin Res. 1994;20(4):169-76. Salvioli G et al.
P. 305: Ginko Biloba improves memory by suppressing and reversing amyloid beta: 

J Neurosci. 2006 Dec 13;26(50):13102-13. Wu Y et al.; Planta Med. 2006 Nov;72(14):1296-9. Brunetti L et al.
P. 305: Ginko protects brain cells from effects of NMDA: 

Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2479-84. Xiao ZY et al.
P. 305: Ginko increases brain oxygen supply, promotes antioxidant production, and production of free radicals: 

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Sep;26(9):795-8. Deng YK et al.
P. 305: Ginko shown to prevent age-related memory loss: 

Exp Neurol. 2003 Nov;184(1):510-20. Stackman RW et al.
P. 305: Ginko increased positive performance in Alzheimer’s patients at least as good as common drug without the drug side effect: 

Eur J Neurol. 2006 Sep;13(9):981-5. Mazza M et al.
P. 305: Ginko protect from ovarian cancer: 

Cancer Lett. 2006 Dec 26; Ye B et al.
P. 306: Huperzine A acts as a acetylcholinesterase inhibitor: 

Acta Pharmacol Sin. 2006 Jan;27(1):1-26. Wang R et al.
P. 306: Huperzine has been shown to improve memory in adults with mild memory loss and in patients with Alzheimer’s: 

Acta Pharmacol Sin. 2006 Jan;27(1):1-26. Wang R et al.
P. 306: Vinpocentine is used to treat memory loss associated with cerebrovascular cognitive diseases: 

Eur J Pharmacol. 1990 Oct 23;187(3):551-3. Erdo SL et al.
P. 306: Vinpocentine protects brain cell from cell destruction: 

Eur J Pharmacol. 1990 Oct 23;187(3):551-3. Erdo SL et al.; Ideggyogy Sz. 2003 May 20;56(5-6):166-72. Hadjiev D.
P. 307: Galantamine effective in Alzheimer’s patients: 

Cochrane Database Syst Rev. 2002;(3):CD001747. Olin J et al.; Drugs Aging. 2003;20(10):777-89. Wilcock G et al.
P. 307: Galantamine more effective and non toxic compare to drug (Aricept) for treatment of memory loss: 

Drugs Aging. 2003;20(10):777-89. Wilcock G et al.
P. 307: Wide use of Galantamine as remedy for mild memory loss: 

Cochrane Database Syst Rev. 2002;(3):CD001747. Olin J et al.
P. 308: Hydergine helpful at improving memory loss: 

Arch Neurol. 1994 Aug;51(8):787-98. Schneider LS et al.; Curr Med Res Opin. 1986;10(4):256-79. Huber F et al.
P. 308: Hydergine is an MAO inhibitor: 

Eur Neuropsychopharmacol. 1995 Dec;5(4):527-9. Buyukozturk A et al.
P. 308: Aniracetam improves memory by increasing supply of PI3: 

Eur J Pharmacol. 2004 Jun 28;494(2-3):111-20. Gabryel B et al.
P. 308: Aniracetam increases dopamine and serotonin levels: 

Brain Res. 2001 Oct 19;916(1-2):211-21. Shirane M et al.; Pharmacol Biochem Behave. 2001 Jan;68(1)65-9. Nakamura K et al.; Brain Res Brain res Rev. 1994 May;19(2):180-222. gouliaev AH et al.
P. 308: Piracetam improve vertigo and dyslexia: 

CNS Drug Rev. 2005 Summer;11(2):169-82. Winblad B.
P. 308: Piracetam has shown to improve learning and memory in health adults: 

Psychopharmaco. 1976;49:307-09. Dimond SJ et al.
P. 308: Piracetam reverse memory loss from electric shock and barbiturate intoxication: 

Brain Res Brain res Rev. 1994 May;19(2):180-222. Gouliaev Ah et al.
P. 308: In extreme cases, Aniracetam and Piracetam shown to improve memory loss: 

Neuroprotection. May 20;56(5-6):166-72. Haddjiev D et al.
P. 308: Centrophenoxine improves memory by reducing lipofuscion: 

Neurobiol Aging. 1986 Mar-Apr;7(2):107-13. Andrews LD et al.; J Gerontol. 1983 Sep;38(5):525-31. Katz ML et al.
P. 308: Centrophenoxine reverses aluminum toxicity associated with Alzheimer’s: 

Mol Cell Biochem. 2006 Oct;290(1-2):185-91. Nehru B et al.
P. 310: Suboptimal thyroid levels associated with severe brain atrophy: 

Neuroepidemiology. 2006;27(2):89-95. Reitz C et al.
P. 310: Addressing thyroid definiciency improves cognitive function and verbal memory: 

Int J Neurosci. 2006 Aug;116(8):895-906. Miller KJ et al.
P. 310: Melatonin inhibits generation of beta-amyloid and tau hyperphosphorylation: 

Acta Pharmacol Sin. 2006 Jan;27(1):41-9. Wang JZ et al.
P. 310: DHEA and testosterone protect against Alzheimer’s: 

J Neurosci. 2002 Jun 15;22(12):5204-9. Raber J et al.
P. 311: Testosterone supplementing can improve women’s visual and spatial memory: 

Psychoneuroendocrinology. 2004 Jun;29(5):612-7. Aleman A et al.
P. 311: Bioidentical progesterone improves memory by calming, improving sleep, and providing general cognitive protection: 

Ann N Y Acad Sci. 2005 Jun;1052:152-69. Stein DG.
P. 311: Progesterone shown to prevent damage caused by brain trauma and to enhance the rate of recovery: 

Neuroscience. 2004;123(2):349-59. Djebaili M et al.; Exp Neurol. 2002 Nov;178(1):59-67. Shear DA et al.
P. 311: Progesterone increase BDNF and protect against glutamate toxicity: 

J Neurosci Res. 2007 Jun 4;85(11):2441-2449. Kaur P et al.
P. 312: Pregnenolone stimulates brain cell production in hippocampus: 

Neurobiol Aging. 2005 Jan;26(1):103-14. Mayo W et al.
P. 312: Pregnenolone protects brain cells from glutamate and amyloid beta protein toxicity: 

Neurochem Res. 2001 Jan;26(1):15-21. Gursoy E et al.
P. 313: Human growth hormone is big help to the brain: 

Horm Res. 2005;64 Suppl 3:109-14. Van Dam PS.; Horm Res. 2005;64 Suppl 3:100-8. Maruff P et al.
P. 313: Removal of one or two ovaries before menopause increase cognitive decline: 

Neurology. 2007 Aug 29; Rocca WA et al.
P. 314: Physical activity improves learning, memory and overall cognitive function: 

Nutr Health. 2006;18(3):277-84. Pinilla FG.
P. 314: Treadmill running improves rate of brain cell production in hippocampus: 

Brain Res. 2006 Aug 9;1104(1):64-72. Uda M et al.
P. 314: Exercise improves negative effects of high fat diet: 

Nutr Health. 2006;18(3):277-84. Pinilla FG.; Neuroscience. 2004;123(2):429-40. Molteni R et al.
P. 314: Women between ages 59-68 improve cognitive performance after three months of exercise: 

J Physiol Pharmacol. 2006 Sep;57 Suppl 4:417-24. Zlomanczuk P et al.
P. 314: Combination of mental and aerobic training shows greater improvement than either alone: 

Int J Sports Med. 2002 Aug;23(6):415-21. Fabre C et al.
P. 315: Stress associated with brain atrophy: 

CNS Neurol Disord Drug Targets. 2006 Oct;5(5):503-12. Bremner JD.
P. 315: Brain shrinks as consequence of trauma: 

Biol Psychiatry. 2002 Jul 15;52(2):119-25. Villarreal G et al.
P. 315: More interpersonal stress adults experience, greater rate of memory failure on day-to-day basis: 

Psychol Aging. 2006 Jun;21(2):424-9. Neupert SD et al.
P. 316: Studies indicate that yoga assist brain in healing: 

Psychol Aging. 2006 Jun;21(2):424-9. Neupert SD et al.
P. 316: Studies indicate that praying assist brain in healing: 

Percept Mot Skills. 1999 Jun;88(3 Pt 1):765-70. Febbro F et al.
P. 316: Studies indicate that meditation assist brain in healing: 

Int J Clin Exp Hypn. 2004 Oct;52(4):434-55. Wagstaff GF et al.
P. 316: Tai Chi Chuan helpful after head trauma: 

Arch Phys Med Rehabil. 2001 Sep;82(9):1283-5. Shapira MY et al.
P. 316: Sleep depravation is chronic stress inducer: 

Metabolism. 2006 Oct;55(10suppl 2):S20-3. McEwen BS.
P. 316: Sleep depravation impairs spatial memory and impairs hippocampal function: 

Brain Res. 2004 Aug 20;1018(1):38-47. Guan Z et al.
P. 317: Resolving sleep apnea with use of PAP mask restores much of lost cognitive function: 

Chest. 2006 Dec;130(6):1772-8. Zimmerman ME et al.
P. 317: Association between depression and subsequent decline cognitive function: 

Arch Gen Psychiatry. 2006 Feb;63(2):130-8. Steffens DC et al.
P. 317: By incorporating four pillars, woman are able to improve cognitive function: 

Am J Geriatr Psychiatry. 2006 Jun;14(6):538-45. Small GW et al.

P. 321: Significant increase of osteoporosis and bone fracture when women stop to take estrogen: 

Climacteric. 2007 Aug;10(4):273-5. gambaccini M et al.
P. 321: Osteoporosis a major public health threat: 

Contracept Technol Update. 2000 Aug;21(8):95-6 et al.
P. 321: Poor diet, lack of vitamins and minerals and bone loss: 

Nippon Rinsho. 2006 Sep;64(9):1639-43. Katagiri H.; Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.; Clin Ter. 2005 Jan-Apr;156(1-2):47-56. Miggiano GA et al.; Osteoporosis Int. 2006;17(7):1022-32. Rude RK et al.
P. 321: Bone loss due to inflammation: 

Inflamm Res. 2004 Nov;53(11):596-600. Haynes DR.
P. 321: Vitamin D prevent and treat bone loss: 

Nippon Rinsho. 2006 Sep;64(9):1639-43. Katagiri H.; Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.; Clin Ter. 2005 Jan-Apr;156(1-2):47-56. Miggiano GA et al.
P. 321: Magnesium deficiency and bone loss: 

Osteoporosis Int. 2006;17(7):1022-32. Rude RK et al.; Ir J Med Sci. 2001 Jan 邦ar;170(1):58-62. O達rien M.
P. 321: Lack of exercise and bone loss: 

J Ir Med Sci. 2001 Jan-Mar;170(1):58-62. O達rien M.
P. 321: Use of very low-dose birth control pills may induce bone loss: 

Bone 2007 Feb;40(2):444-50. Hartard M et al.; Curr Opin Obstet Gynecol. 2003 Oct;15(5):353-7. Cromer BA.
P. 321: Use of Depo-Provera cause bone loss: 

Hong Kong Med J. 2005 Dec;11(6):491-5. Lo SS et al.
P. 321: Use of acid-blocking medications like Zantac and Nexium cause bone loss: 

JAMA. 2006 Dec 27;296(24):2947-53. Yang YX et al.
P. 321: Use of anti-depressants like Prozac and Zolof cause bone loss: 

Lakartidningen. 2005 Sep 26-Oct 2;102(39):2746-9. Lerner UH.
P. 322: Use of aromatase inhibitors cause bone loss: 

Oncologist. 2006 Nov-Dec;11(10):1058-69. Perez EA.; Oncology (Williston Park). 2006 Aug;20(9):1029-39; discussion 1039-40, 1042, 1048. Perez EA et al.
P. 322: Risk of jaw bone necrosis with conventional osteoporosis medications: 

Oncology (Williston Park). 2006 Aug;20(9):1029-39; discussion 1039-40, 1042, 1048. Perez EA et al.
P. 323: The longer the use of conventional osteoporosis medications, the more they accumulate and remain in the bones: 

J Clin Eno & Metab. 2005:90(3) 1897-1899. Ott SM.
P. 323: Fracturing bones while on Fosemax, Boniva may cause slow and inefficient healing: 

J Clinic Endo & Metab. 2005;90(3):1294-1301. Odvina C et al.; J Clin Eno & Metab. 2005:90(3) 1897-1899. Ott SM.
P. 323: Long term use of osteoporosis medications like Fosemax and Boniva may leade to heart attack and stroke: 

Circulation 1999;100:446-449. Goldstein MR.
P. 323: Estrogen deficiency cause osteoporosis: 

Ir J Med Sci. 2001 J-Mar;170(1):58-62. O達rien M.
P. 323: Stoping to take estrogen cause osteoporosis: 

Climacteric. 2007 Aug;10(4):273-5. Gambacciani M et al.
P. 323: Fosemax and Boniva, etc suppress (significant decrease) bone build up: 

J Clin Endo & Metab. 2005;90(3):1897-1899. Ott SM.; J Clinic Endo Metab. 2005;90(3):1294-1301. Odvina C et al.
P. 324: Magnesium help and protect the bone: 

Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.; Osteoporos Int. 2006;17(7):1022-32. Rude RK et al.
P. 324: Vitamin D protect the bone: 

Nippon Rinsho. 2006 Sep;64(9):1639-43. Katagiri H./ Crit Rev Food Sci Nutr. 2006;46(8):621-8. Palacios C.
P. 324: Vitamin D in high dose may increase vascular calcification: 

Circulation. 1998;98(13):1302-6. Jono S et al.
P. 324: Vitamin D strength muscle of patient with previous fractures: 

N Z Med J. 2007 Sep 21;120(1262):U2730. Inderjeeth CA et al.
P. 324: Omega 3 fish oil protect the bone: 

Clin Ter. 2005 Jan-Apr;156(1-2):47-56. Miggiano GA et al.
P. 324: Strontium is effective bone builder in spine and hips: 

Int J Clin Pract. 2007 Feb;61(2):324-8. Reginster JY et al.; Int J Clin Pract. 2007 Feb;61(2):324-8. Reginster JY et al.; Bone. 2007 May;40(5 Suppl 1):S5-8. Marie PJ.; Cochrane Database Syst Rev. 2006 Jul 19;3:CD005326. O奪onnell S et al.
P. 324: Boron has affect on bone build up: 

Biol Trace Elem Res. 1992 Dec;35(3):225-37. Nielsen FH et al.; Br J Nutr. 1993 May;69(3):871-84. Beattie JH et al.; J Clin Densi Tom. 2002 Summer;5(2)187-92. Rico H et al.
P. 324: Weight bearing exercise encouraged for building bone: 

J Ir Med Sci. 2001 Jan-Mar;170(1):58-62. O達rien M.

P. 326: Studies indicate women’s fears of breast cancer far exceed reality: 

Presentation South Atlantic Association OB/Gyn Boca Raton 2004 Levin.
P. 327: Diet and environmental exposure during pregnancy increase risk of future breast cancer: 

Trends Endocrinol Metab. 2006 Nov;17(9): 340-8. Hilakivi-Clarke L et al.
P. 327: Prenatal exposure to bisphenol (very common estrogen like chemical) induces breast cancer: 

Environ Health Perspect. 2007 Jan;115(1):80-6. Durando M et al.; Environ Health Perspect. 2007 Apr;115(4):592-8. Wadia PR et al.
P. 327: Alcohol consumption during pregnancy and risk of future breast cancer in unborn daughter: 

Br J Cancer. 2004 Jun;1;90(11): 2225-31. Hilakivi-Clarke L et al.
P. 327: High-fat diet and significant weight gain during pregnancy increase rates of breast cancer in offspring: 

Int J Cancer. 2006 Oct 1;119(7): 1537-46. De Assis S et al.
P. 327: Use of DES increases occurrence of breast cancer in unborn daughters: 

Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
P. 327: Study: adult women who have gained 55 pounds experience increased risk of breast cancer: 

JAMA. 2006 Jul 12;296(2):193-201. Eliassen AH et al.; Semin Oncol. 2006 Apr;33(2 Suppl 7):2-7. Forbes JF.
P. 328: Birth control significantly increase incidence of breast cancer, risk is much higher if oral contraceptive start at young age: 

Breast Cancer Res Treat. 1998 Jul;50(2):175-84. Ursin G et al.; J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. White E et al.; Contraception. 1996 Sep;54(3 Suppl):1S-106S.
P. 328: Teenage pregnancy decreases breast cancer for life: 

Int J Food Sci Nutr. 1995 Nov;46(4):373-81. Walker AR et al.
P. 328: Gain of more than 22 pounds since menopause increases risk of breast cancer: 

JAMA. 2006;296: 193-201. Eliassen AH et al.
P. 328: Consumption of bad fat (Omega 6) increase risk of breast cancer: 

Cancer Causes Control. 2002 Dec;13(10): 883-93. Wirfalt E et al.
P. 328: Red meat increases risk of breast cancer: 

Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
P. 328: More than 1.5 servings of red meat a day increases risk of breast cancer bt 97%: 

Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
P. 328: Increased risk of breast cancer by taking birth control between the ages of 15 and 20: 

Eur J Cancer. 2005;41(15): 2312-20. Jernstrom H et al.
P. 329: Weight and girth gain during pregnancy increases breast cancer risk: 

J Nutr. 2006 Apr;136(4): 998-1004. De Assis S et al.
P. 329: Waist hip ratio and weight gain over life time increases breast cancer risk: 

International J of Cancer. 2002;99: (3): 445-52. Friedenreich CM et al.
P. 329: Weight gain of 38 pounds during pregnancy increase breast cancer risk: 

American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
P. 329: Antibiotic treatment significantly increases risk for breast cancer: 

JAMA. 2004;291(7): 827-35. Christine M et al.
P. 329: Increased breast cancer risk due to proliferation of abnormal bacteria due to antibiotic treatment: 

Cancer Res. 2007 Feb 1;67(3): 847-50. Rao VP et al.
P. 329: Certain groups more susceptible to environmental pollutants:

 Contraception. 1996 Sep;54(3 Suppl):1S-106S.
P. 330: Study: significant stress doubles breast cancer risk: 

LA Time. Sep 24, 2002 Health section cancer Conference Copenhagen et al. Med Hypotheses. 2007;68(5):1138-43. Gago-Dominguez M et al.; Mol Cell Biochem. 2007 Aug 11; Zweitzig Dr. et al.
P. 330: Job strain increase risk of breast cancer: 

Epidemiology. 2007 Sug 30; Kuper H et al.
P. 330: Stress history increase recurrence of breast cancer: 

J Psychosom Res. 2007 Sep;63(3):233-9 Palesh O et al.
P. 330: Stress increases metastasis marker in breast cancer cell: 

Mol Cell Biochem. 2007 Aug 11; Zweitzig DR et al.
P. 330: Studies demonstrating iodine deficiency increase risk for breast cancer: 

Trans New York Acad Sciences. 1970;32: 911-47. Eskin BA.; Breast. 2001 Oct;10(5):379-82. Venturis S.; Cancer Causes Control. 2000 Feb;11(2):121-7. Cann SA et al.; Adv Exp Med Biol. 1977;91:293-304. Eskin BA.
P. 330: SSRIs like Prozac, Zolof etc. increase uncommon but aggressive type of breast cancer: 

Breast Cancer Res Treat. 2005 Dec 2;: 1-10. Chien C et al.
P. 330: It takes 15 years until 2 breast cancer cells reach size of 1 cm: 

Jpn J Cancer Res. 1990 May;81(5):454-62. Kuroishi t et al.
P. 331: Breast cancer risk drops with each pregnancy by 7%: 

LANCET. 2002;360(9328): 187-95.
P. 331: Women with breast cancer who get pregnant live longer and have less recurrences comparing to women with breast cancer that do not get pregnant: 

BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Ob. Gyn News. 2006 Jul 13: P2. Largillier R.; J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/august;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun 1;85(11):2424-32. Valentgas P et al.
P. 331: Aromatization is the process that converts testosterone to estrogen in the breast: 

J Br Med J 1998;296(6624)741-3. O’Neill JS et al.
P. 331: Inflammation with increase of TNFk, NFKbeta, IL6/IL12 and COX-2 activity promote aromatization and increase aggressiveness metastasis ability and resistance to treatment of breast cancer: 

Endocr Relat Cancer. 2005 Jul;12 Suppl 1: S37-46. Zhou Y et al.; Egypt J Immunol. 2004;11(2): 165-70. Hussein MZ et al.; Endocr Relat Cancer. 2006 Jun;13(2): 607-616. Montagut C et al.; Endocrinology. 2005 Nov;146(11): 4917-25. Saitoh M et al.
P. 331: Women who have 7 or more mammograms increase breast cancer risk by 80%: 

Breast Cancer Res Treat. 2007 Jul 7; Ma H et al.
P. 331: X-ray before age 20 increase breast cancer by 40% in women with cystic breast: 

Cancer Causes Control. 2002 Oct;13(8):711-8. Hill DA et al.
P. 331: Women that have radiation as treatment for breast cancer have significant increase in heart attack incidence: 

Radiother Oncol. 2007 Mar;82(3):294-300. Paszat LF et al.
P. 331: Grapefruit intake may increase risk of breast cancer: 

Br J Cancer. 2007 Jul 10; Monroe KR et al.
P. 331: Women who where exposed to higher dose of DDT at young age has significant risk of increase breast cancer: 

Los Angeles Times, By Maria Cone. September 30 2007: Chief investigator Cohn BA.
P. 331: Indole-3-carbinol abolish negative affect of DDT on the breast: 

Acta Biochim Pol. 2007;54(1):113-7. Ociepa-Zawal M et al.
P. 331: Exposure to higher dose of DDT increases breast cancer: 

J Natl Cancer Inst. 1993 Apr 21;85(8):648-52. Wolff MS et al.
P. 331: Excessive iron increases the risk of breast cancer: 

Cancer Causes Control. 2007 Dec;18(10):1047-53. Kabat GC et al.;
P. 331: Genetic risk for increase iron level associated with increase post menopausal breast cancer: 

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1784-94. Hong CC et al.
P. 331: HPV virus Epstein-Bar virus and mouse mammary tumor virus may have a role in the development of cancer: 

Future Microbiol. 2006 Jun;1:33-51. Lawson JS et al.
P. 331: Oxidative stress contribute to the development of breast cancer: 

Clin Biochem. 2007 Oct;40(15):1129-34. Delimaris I et al.
P. 331: Progesterone and 17 Beta HSD 2 metabolize estradiol to estrone: 

Breast Cancer. 2006:13(2): 129-36. Sasano H et al.
P. 332: Evening primrose oil (gamma linolenic acid) enhances positive treatment result of women with Her-2/neu expression in breast cancer: 

J Natl Cancer Inst. 2005 Nov 2:97(21):1611-5. Menendez JA et al.
P. 332: Evening primrose oil (GLA) may be protecting breast cancer metastasis: 

J Cell Biochem. 2007 May 1;101(10):155-66. Martin TA et al.
P. 332: Flax seed slow breast cancer metastasis by decrease VEGFs: 

Cancer Lett. 2002 Nov 8;185(1):31-7. Dabrosin C et al.
P. 332: Flax seed inhibit breast cancer and improve tamoxifen treatment: 

Clin Cancer Res. 2004 Nov 15;10(22):7703-11. Chen J et al.
P. 332: Fish oil protects us from breast cancer: Int J Cancer. 2005 Nov 10;117(3): 

340-8. Wu M et al.; Breast Cancer Res Treat. 1995 Jun;34(3): 199-212. Chajes V et al.; Oncol Rep. 2007 Apr;17(4):713-9. Jourdan ML et al.
P. 332: Fish oil and vitamin E decrease breast cancer cell growth: 

Breast Cancer Res Treat. 1995 Jun;34(3):199-212. Chajes V et al.
P. 332: Perimenopausal women cosuming more Omega-3 and less Omega-6 less likely to develop breast cancer: 

J Nutr. 2003 May;133(5): 1409-14. Goodstine SL et al.
P. 332: CLA inhibits cell proliferation in cancer cells: 

Exp Mol Pathol. 2005 Oct;79(2): 118-25. Albright CD et al.
P. 332: Whey and whey acid proteins inhibits proliferation and spread of breast cancer: 

J Cell Physiol. 2007 May31; Nukumi N et al.; Cancer Lett. 2007 Jul 8;252(1):65-74. Nukumi et al.
P. 333: Soy and soy products decrease breast cancer and decrease breast cancer resistance to treatment: 

Oncogene. 2005 Apr 7;24(15):2558-67. Kim SO et al.; J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. Touillaud MS et al.; Cancer Res. 2004 Jun 15;64(12):4346-52. Imai Y et al.
P. 333: Consuming ginger may dcrease breast cancer resistance: 

Oncogene. 2005 Apr 7;24(15): 2558-67. Kim So et al.
P. 333: Curcumin’s anti-inflammatory and anti-tumor affect as significant protection from breast cancer: 

Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Anticancer Res. 2005 Sep-Oct;25(5): 3293-302. Ramachandran C et al.; Int J Mol Med. 2007 Sep;20(3):329-35. Poma P et al.; Cancer Res. 2007 Apr 15;67(8):3853-61. Kunnumakkara AB et al.
P. 333: Investigation of green tea as treatment for breast cancer: 

IDrugs. 2003 Nov: 6(11): 1073-8. Rosengren RJ.
P. 333: Green tea as an anti-inflammatory and COX-2 inhibitor: 

Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Int J Cancer. 2005 Feb 10;113(4): 660-9. Hussain T et al.
P. 333: Green tea decreases aggressive nature of cancer cells: 

Nutr Cancer. 2005;52(1): 66-73. Slivova V et al.
P. 333: Green tea inhibiting destructive effect of Her-2/neu and (EGFR) that are significant risk factor in breast cancer: 

Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
P. 333: Green tea enhances efficiency of Taxol: 

Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
P. 333: Taxol standard breast cancer toxic chemotherapy found not to be effective but with patients with HER2:
P. 333: Grape juice, grape seeds, and red wine as aromatase inhibitors for prevention of breast cancer: 

Ann N Y Acad Sci. 2002;963: 229-38. Chen S.; Cancer Res. 2006 Jun 1;66(11): 5960-7. Kijima I et al.; Breast Cancer Res Treat. 2001 May;67(2): 133-46. Eng ET et al.; Ann N Y Acad Sci. 2002 Jun;963: 239-46. Eng ET et al.
P. 334: Resveratrol is a COX-2 inhibitor: 

Biofactors. 2004;21(1-4): 33-9. Kundu JK et al.
P. 334: Resveratrol is a NFkB inhibitor: 

Int J Mol Med. 2006 Jun;17(6): 1069-75. Kim YA et al.
P. 334: Resveratrol regresses tumor formation: 

Arch Int Med. 1991;151: 75. Henderson BE et al.
P. 334: Resveratrol as a reason for the so-called “French Paradox”: 

Mol Nutr Food Res. 2005 May;49(5): 452-61. Ulrich S et al.
P. 334: Pomegranates decrease NFkB: 

Int J Cancer. 2005 Jan 20;113(3): 423-33. Afaq F et al.; Breast Cancer Res Treat. 2002 Feb;71(3): 203-17. Kim ND et al.
P. 334: Pomegranates decrease breast cancer cell proliferation: 

J Med Food. 2005 Winter;8(4): 469-75. Jeune MA et al.
P. 334: Pomegranate prevents breast cancer cells from developing new blood vessels and progression: 

Angiogenesis. 2003;6(2): 121-8. Toi M et al.; Eur J Cancer Prev. 2004 Aug;13(4): 345-8. Mehta R et al.
P. 335: Mushrooms that serve as a treatment option for estrogen receptor negative breast cancer: 

Oncol Rep. 2006 Feb;15(2): 417-23. Gu YH et al.
P. 335: Ganoderma lucidum mushrooms down regulate NFkB inhibit breast cancer: 

Int J Oncol. 2006 Sep;29(3): 695-703. Jiang J et al.
P. 335: White button mushroom is chemo preventive in breast cancer via anti aromatase activity: 

J Nutr. 2006 Apr;136(4):998-1004. de Assis S et al.
P. 335: Perimenopausal women consuming more than 30 grams of fiber daily decrease breast cancer: 

Int J Epidemiol 2007 Apr;36(2):431-8. Cade J et al.
P. 335: 2 Metoxyestradiol protect against breast cancer: 

Circ Res. 2006 Aug 4;99(3): 266-74. Barchiesi F et al.
P. 335: 16 Hydroxy esterone increase breast cancer risk: 

Maturitas. 2006 Apr 20;54(1): 72-7. Seeger H et al.
P. 335: Breast cancer patients have higher levels of 16 Hydroxy esterone: 

Cancer Epidemiol Biomarkers Prev. 1997;6: 505-9. Kabat GC et al.
P. 335: Breast cancer patients have lower levels of 2 Hydroxy esterone: 

Epidemiology. 2000 Nov;11(6):635-40. Muti P et al.; Epidemiology. 2006 Jan;17(1):80-8. Kabat GC et al.; Steroids. 2003 Jan;68(1):65-72. Fowke JH et al.
P. 335: DIM supplements increase 2 Hydroxy esterone and may protect from breast cancer: 

Nutr Cancer. 2004;50(2): 161-7. Dalessandri KM et al.
P. 335: Indol3 Carbinol supplements increase 2 Hydroxy esterone: 

J Cell Biochem Suppl. 1997;28-29: 111-6. Wong GY et al.; Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Oncogene. 2001 May 24;20(23): 2927-36. Chinni SR et al.
P. 335: Indol3 Carbinol reduces epidermal growth factor receptors that usually increase cancer progresion: 

Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Carcinogenesis. 2007 Feb;28(2): 435-45. Moiseeva EP et al.
P. 335: High level of 2 Hydroxyesteron associated with osteoporosis: 

J Clin Endo Meta. 2005;90(4):2035-2041. Napoli N et al.; J Bone Miner Res. 2000 Dec;15(12):2513-20. Leelawattana R et al.
P. 335: Breast cancer associated with increase bone density: 

Maturitas. 2006 Oct 16; Hadju P et al.
P. 335: Snips in 1B1 increase 4 OH estrone that increase breast cancer: 

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3): 209-216. Goodman MT et al.; Cancer Res. 2000 Jul;60(13):3440-3444. Hanna IH et al.; Endocr Rev. 2000 Feb;21(1):40-54. Liehr JG.; Afr J Reprod Health. 2006 Apr;10(1):13-25. Okobia MN et al.
P. 335: Women with SNP in 1B1 have a 220% increase in risk of breast cancer: 

Cancer Epidemiol Biomarkers Prev. 2000;9(2):147-150. Zheng W et al.
P. 335: DHEA suppresses production of 4 Hydroxy esterone: 

Mol Cell Biochem. 1999 Aug;198(1-2) 89-100. Ikegwuonu FI et al.
P. 335: COMT defect increases breast cancer: 

Cancer Res. 1998;58: 2107-2110. Thompson PA et al.; Cancer Res. 1999;59: 4870-4875. Huang CS et al.; Cancer Res. 1997 Dec 15;57(24):5493-7. Lavigne JA et al.
P. 335: Overweight women with COMT defect have higher risk of breast cancer: 

Cancer Res. 1998 May 15;58(10):2107-10. Thompson PA et al.; Cancer Res. 1999 Oct 1;59(19):4870-5. Huang CS et al.
P. 335 COMT defect and Folic Acid deficiency are risk for breast cancer: 

Carcinogenesis. 2001;22(10): 1661-1665. Goodman JE et al.
P. 335: GST protects from pollutants and toxins: 

Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.
P. 335: GST SNP defect increase breast cancer risk by 50%: 

Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.; J Natl Cancer Inst. 1998;90: 512-518. Helzlsouer KJ et al.
P. 335: Combination of SNPs in COMP and GST further increase breast cancer risk: 

Pharmacogenetics. 2002;12: 67-72. Mitrunen K et al.
P. 335: Uderstanding personal risk of developing breast cancer: 

Fertil Steril. 2004 Jul;82(1):132-7. Clemens B et al.
P. 335: Hope is aromatase inhibitor and may decrease breast cancer: 

J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.;
P. 336: Sulforaphane (SGS) stop breast cancer growth: 

Drug Discov Today. 2004 Nov 1;9(21):908. Johnston N.; Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.; Mol Cancer Ther. 2007 Mar;6(3):1013-21. Pledgie-Tracy A et al.; Mol Cells. 2005 Dec 31;20(3):364-70. Kim SJ et al.; Life Sci. 2006 May 22;78(26):3043-50. Thejass P et al.; Vascul Pharmacol. 2007 Feb;46(2):77-84. Jackson SJ et al.;
P. 335: Royal jelly inhibits growth in breast cancer cells: 

Biosci Biotechnol Biochem. 2007 Jan;71(1): 253-5. Nakaya M et al.
P. 336: Quercetin increases protection from breast cancer: 

Cancer Biol Ther. 2007 Jan 29;6(1). Dechsupa S et al.
P. 336: Selenium down-regulated estrogen Receptor Alpha expression: 

Breast Cancer Res Treat. 2005 Aug;92(3): 239-50. Shah YM et al.; J Cell Biochem. 2007 Jan 22; Martin TA et al.
P. 336: Vitamin E Tocotrienol functions as an anti-cancer mechanism in pre-cancer and cancer cells: 

Exp Biol Med. 2005 Apr;230(4): 235-41. Shah SJ et al.; Asia Pac J Clin Nutr. 2005;14(4): 366-73. Sylvester PW et al.; Ann N Y Acad Sci. 2004 Dec;1031: 143-57. Nesaretnam K et al.; Biochem Biophys Res Commun. 2006 Jul 28;346(2): 447-53. Srivastava JK et al.; Cancer Detect Prev. 2005;29(4): 383-8. Yu FL et al.
P. 337: Vitamin D decreases growth of breast cancer cells: 

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2): 103-9. Townsend K et al.; J Steroid Biochem Mol Biol. 2003 Feb;84(2-3): 149-57. Wietzke JA et al.; Oncogene. 2000 Oct 19;19(44): 5091-7. Campbell MJ et al.; Acta Pharmacol Sin. 2007 Sep;28(9):1373-82. Welsh J.
P. 337: Co-Enzyme Q10 produces complete and partial remission of breast cancer: 

Biochem Biophys Res Commun. 1994 Mar 30;199(3): 1504-8. Lockwood K et al.
P. 337: Lycopene is a suppressor of the initiation process of breast cancer: 

Pharmacogenomics. 2006 Jul;7(5): 663-72. Chalabi N et al.; Toxicol In Vitro. 2007 Mar;21(2):217-23. Fornelli et al.
P. 337: Vitamins B-12 and B-6 decrease incidence of breast cancer: 

J Natl Cancer Inst. 2003 Mar 5;95(5): 373-80. Zhang SM et al.
P. 338: Physical activity decreases the risk of invasive breast cancer: 

Cancer Epidmed Biomarkers Prev. 2007 Feb;16(12): 236-43. Sprague BL et al.
P. 338: Physical activity decrease estrogen-Positive progesterone-Negative breast cancer: 

Arch Intern Med. 2006 Dec 11-25;166(22): 2478-83. Bardia A et al.
P. 338: 1991 Harvard University study about wearing bras and increase incidence of breast cancer: 

Eur J Cancer. 1991 27: 131-5. Hsieh CC et al.
P. 339: Bra use decreases Melatonin: Chronobiol Int. 2000 Nov;176: 

783-93. Lee YA et al.
P. 339: Large bra cup sizes in young women increase risk of perimenopausal breast cancer: 

Int J Cancer. 2006 Apr 15;118(8): 2031-4. Kusano AS et al.
P. 339: Bra use for 18-24 hours per day increase breast cancer risk more than 100 fold: 

Dressed To Kill 1995. Avery Press Singer S et al.
P. 339: Stoping to use bra stop shoulder pain: 

Clin Endocrinol 2006;64(1)20-8. Enriori PJ et al.
P. 340: Study indicating that bra wear results in future breast sagging: 

J Hum. Ergol. 1990 Jun; 19(1): 53-62. Ashizawa K et al.
P. 340: Higher incidence of breast cancer in upper, outer quadrant of breast: 

J Appl Toxicol. 2003 Mar-Apr;23(2): 89-95. Darbre PD.
P. 340: Nearly everything applied to upper, outer quadrant is toxic: 

Appl Toxicol. 2003 Sep-Oct;23(5): 285-8. Harvey PW.
P. 340: Parabens has been identified in breast cancer tissue: 

J Appl Toxicol. 2005 Jul-Aug;25(4): 301-9. Pugazhendhi D et al.; J Appl Toxicol. 2004 May-Jun;24(3):167-76. Harvey PW et al.
P. 340: Aluminum in antiperspirants associated with DNA alteration: 

J Inorg Biochem. 2005 Sep;99(9): 1912-9. Darbre PD.
P. 340: Studies indicating longer use of anything on underarm, the earlier breast cancer diagnosis: 

Eur J Cancer Prev. 2003 Dec;12(6): 479-85. McGrath KG.
P. 341: Full-term pregnancy and breast feeding decrease incidence of breast cancer: 

LANCET. 2002;360(9328): 187-95.
P. 341: Pregnancy after breast cancer increase survival and decrease cancer recurrence comparing to breast cancer survivor that did not get pregnant: 

BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/August;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun1;85(11):2424-32. Velentgas P et al.; Los Angeles Times. 2007 Sept 30;UC Berkley study main investigator. Barbara A Cohn.
P. 341: Teenage pregnancy associated with decreased risk of breast cancer: 

Int J Food Sci Nutr. 1995 Nov;46(4): 373-81. Walker AR et al.
P. 341: Mice given high doses of estrogen and progesterone at puberty reduced breast cancer by 60%, and eliminated HER-2/neu (HER-2): 

Breast Cancer Res. 2007 Jan 26;9(1): R12. Rajkumar L et al.
P. 341: Breastfeeding decreases incidence of cancer by 4.3%: 

LANCET. 2002;360(9328): 187-95.
P. 341: Nipple stimulation releases duct obstruction and free-radicals and may decrease breast cancer: 

Med Hypotheses. 1991 Dec;36(4): 389-96. Murrell TG.; Breast Cancer Res Treat. 1995 Aug;35(2): 225-9. Murrell TG.
P. 342: Progesterone increases the production of oxitocyn: Breast Cancer Res Treat. 1995 Aug;35L2):

225-9. Murrell TG.
P. 342: Dhea and androgen protect from breast cancer: 

Endocrine Related Cancer. 2006;13:335-355. Labrie F.
P. 342: Dhea and androgens inhibits breast cancer: 

Endo Review. 2003;24(2)”152-182. Labroe F et al.
P. 342: Dhea decrease breast cancer proliferation: 

Cancer J. 2006 Mar-Apr;12(2):160-5. Gayosso V et al.
P. 342: Dhea stop progression of breast cancer: 

Breast Cancer Res. 2005;7(6):R1132-40. Shilkaitis A et al.
P. 342: Dhea and androgens are chemopreventive and novel cancer anti-proliferative by multiple mechanism: 

Curr Pharm Des. 2006;12(26):3411-21. Matsuzaki Y et al.
P. 342: Dhea protect from breast cancer: 

Endo Relat Cancer. 2006 Jun;13(2):335-355. Labrie F.
P. 342: Dhea is chemoprotive against breast cancer: 

Int J Cancer. 2003 Jun 20;105(3):321-5. Ciolino H et al.
P. 342: Dhea is a treatment option to treating estrogen negative breast cancer: 

World J Surg. 2007 May;31(5);1041-6. Hardin C et al.
P. 342: Androgen and dhea has inhibitory effect on breast cancer: 

Cancer Res. 2006 Aug 1;66(15):7775-82. Macedo LF et al.
P. 342: DHEA suppresses and prevents growth of 4 Hydroxy esterone: 

C Y Mol Cell Biochem. 1999;198(1-2): 89-100. Ikeawuonu FL et al.
P. 342: DHT inhibits growth of breast cancer: 

Breast Cancer Res. 2005;7(6): R1132-40. Shilkaitis A et al.
P. 342: IGBP-3 inhibits growth of breast cancer: 

Cancer Res. 2004 Mar 15;64(6):2229-37. Kim HS et al.
P. 342: Melatonin decrease breast cancer growth: 

J Pineal Res. 2006 May;40(4): 291-6. Martinez-Campa C et al.
P. 342: Melatonin improve survival rates in animals with untreated breast cancer: 

Mol Cell Biochem. 2005 Oct;278(1-2): 15-20. Saez MC et al.
P. 342: Melatonin causes the regression of breast cancer by behaving as an aromatase inhibitor: 

Breast Cancer Res Treat. 2005 Dec;94(3): 249-54. Martinez-Campa C et al.
P. 344: Higher estriol levels in pregnancy translate to 58% reduction in future breast cancer: 

Prospective study of Estrogen during pregnancy risk of Breast Cancer; unpublished studies performed at the Public Health Institute in Oakland and funded by USA Army Medical Research. DAMD 17-99-1-9358 et al.
P. 344: Estriol (E3) protect the development of ovarian cancer: 

J Endocrinol. 2007 Jun;193(3):421-33. Treeck O et al.
P. 344: Adiponectin protects from breast cancer: 

J Clin Endocrinol Metab. 2007 Apr;92(4):1510-16. Tworoger SS et al.
P. 345: Use of bioidentical estradiol and progesterone promotes decrease in breast cancer: 

Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.; Gynecol Endocrinol. 2006 Aug;22(8):423-31. Espie M et al.
P. 345: Women with breast cancer given estrogen enjoyed higher survival rates: 

J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.; Menopause. 2003 Jul-Aug;10(4):277-85. Decker DA et al.
P. 345: Breast cancer surgery during highest level of estradiol enjoys better outcomes: 

Eur J Surg Oncol. 2001 Mar;27(2): 152-6. Holmberg L et al.
P. 345: Estrogen increases apatosis: 

J Steroid Biochem Mol Biol. 2000;72(3-4): 89-102. Szelei J et al.
P. 345: Estradiol decreases Interleukin-6: Egypt J Immunol. 2004;11(2): 

165-70. Hussein MZ et al.; J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
P. 345: Estradiol reduces NFkB: Endocr Relat Cancer. 2006 Jun;13(2): 

607-616. Montagut C et al.; J Huazhung Univ Sci Technology Med Sci. 2006;26(1): 53-8. Wang Y et al.; Poster Endocrin Society. 2004 Page 334 P2 119. Liu H et al.; Mol Endocrinol. 2007 Oct 11; Nettles KW et al.
P. 345: Estrogen receptor positive breast cancer is less aggressive: 

J Clinc Oncol. 1998 Sep;16(9): 3115-20. Holi IC et al.
P. 345: Estrogen receptor positive has higher survivol rate: 

Neoplasma. 1993;40(1): 55-7. Heise E et al.; Int J Cancer. 1994 Nov;59(3): 351-6. Nagai MA et al.
P. 345: Estradiol binds to Estrogen Receptor Beta that decrease breast cancer growth: 

Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.
P. 345: Estrogens were common treatment against breast cancer: 

JAMA. 1997;237: 2079-85. Carter AC et al.; Endocrine Therapy In Malignant Disease. 1972;156-158. Stoll BA et al.
P. 346: When conventional treatment fails for breast cancer with anti estrogen drug, adding estrogen can make it work again: 

Breast. 2005 Sep 29. Jordan VC et al.; World J Surg Oncol. 2006 Jul 11;4: 44. Agrawal A et al.; JAMA. 1997;237: 2079-85. Carter AC et al.; Med Pediats Oncol. 1990;18: 317-20. Boyer MJ et al.
P. 346: Animals supplemented with estradiol, experienced a profound reduction in breast cancer tumor size: 

J The National Cancer Institute. 2002 Aug;94(15):1173. Jordan VK et al.; Clin Cancer Res. 2001;7:3156-65. Josleen VC et al.
P. 346: Study showing estradiol treatment decreased breast cancer and the ability of it to multiply: 

Breast Cancer Research 2007 Jan 26. Lakshmanaswamy R et al.
P. 346: Dr. Bush’s summarized 25 years and 50 reports on HRT and ERT and concluded that estrogen treatment is no risk factor for increase breast cancer: 

Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.
P. 346: Dr. Speroff professor OB/GYN of Oregon University said “HRT treatment is beneficial and make breast cancer cells more differential “: 

Menopause. 2007 Oct 8; Speroff L.
P. 347: Studies confirm reduction of cancer death with use of HRT: Am J Obstet Gyn. 2002;186: 

325-34. Nanda K et al.; Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.
P. 347: WHI study’s use of Premarin only show 23% decrease breast cancer: 

JAMA. 2002 Jul 17;288(3): 321-33. Rossouw JE et al.
P. 347: Harvard University study of use of Premarin alone shows no increase of incidence of breast cancer for 15 years: 

Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
P. 347: Harvard University study shows Premarin-only use saw increase of breast cancer only after 20 years in breast cancer: 

LANCET. 1997;350(9084): 1047-59.
P. 348: Risk associated with estrogen-only treatment is equal to risk from eating red meat five times a week: 

Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
P. 348: Risk of breast cancer associated with estrogen-only is equal to taking 50+ days of antibiotics—45%: 

JAMA. 2004;291(7): 827-35. Christine M et al.
P. 348: Risk associated with estrogen-only is lower than risk from gaining more than 38 pounds while pregnant: 

American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
P. 348: With family history of breast cancer, use of HRT decrease of death from breast cancer: 

Ann Inter Med. 1997;127(11): 75-78. Sellers TA et al.
P. 348 Use of HRT prior to cancer diagnosis leads to be better survival rates and decrease of metastasis: 

Br J Cancer. 1999 Jul;80(9): 1453-8. Jernstrom H et al.
P. 348: Use of HRT with breast cancer survivor decrease by 50% cancer recurrence comparing to breast cancer survivors that did not take HRT: 

Women’s Health. 2001 Oct. Desala PJ.; J Reprod Med 2004 Jul;49(7):510-26. Levgur M.
P. 348: Study showing women with breast cancer treated with estrogen had higher survival rates: 

J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.
P. 348: Additional studies showing increased survival rates with use of estrogen in breast cancer survivors: 

J Natl cancer Inst. 2005 Apr 6;97(7):533-5. Von Schoultz E et al.; Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.; Am J Obstet Gyn. 2002;186: 325-34. Nanda K et al.
P. 349: study finding estrogen use in breast cancer survivors did not increase the breast cancer recurrence: 

J Natl Cancer Inst 2005;97(7)533-5. Von Schoultz E et al.
P. 349: Use of HRT to early breast cancer survivor with follow up of more than 30 years show no increase in incidence and recurrence of breast cancer: 

Am J Obstet Gynecol. 2002 Aug;187(2):289-94. Natrajan PK et al.; Obstet Gynecol. 2007 Jun;109(6):1455. Harkins T.
P. 349: Studies confirming increased survival decrease recurrence of cancer with estrogen use in breast cancer survival: 

Amer J OBGyn. 2002 Aug;187(2): 289-94. Puthugramam K et al.; Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
P. 349: Women with breast cancer treated with estrogen has higher survival and decrease recurrence comparing to group of breast cancer survivors not taking estrogen: 

Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
P. 349: Study showing bioidentical estradiol and progesterone caused a 10% reduction in breast cancer incidence compared to nonusers: 

Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.
P. 349: French study of bioidentical estradiol and progesterone showed decrease breast cancer in user comparing to non user: 

Gynecol Endocrinol. 2006 Aug;22(8): 423-31. Espie M et al.
P. 349: Mice with breast similar to women breast treated with bioidentical hormones showed significant reduction in breast cancer formation and progession: 

Breast Cancer Res. 2007;9(2):102. Rajku MAR et al.
P. 349: The fact that use of bioidentical hormones may prevent breast cancer got notice and positive suggestions: 

Breast cancer Res. 2007;9(2):102. Jerry DJ
P. 349: Estrogen preventive effect on the breast may be blocked by metabolite of cholesterol 27-Hydroxycholesterol: 

Mol Endocrinol. 2007 Sep 13; Dusell CD et al..
P. 349: WHI study warnings: 

Ob.Gyn. News. 2007 Jan 1;42(1): 1. Jancin B et al.
P. 349: Dr. Leon Speroff’s speaking publicly about problems with WHI study, “…diagnostic and selection biases…”: 

Ob Gyn News October 1, 2006. Dixon BK.
P. 349: The world is embracing the use of estrogen and progesterone and emphasizing the safety of natural hormones comparing to the chemicalize hormones: 

Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.; Bull Cancer. 2007 May 1;94(5):469-75. Czernichow C et al.; Med J Aust. 2007 Jun 18;186(12):643-6. MacLennan AH.

What People are Saying

quote-open